# UNITED STATES PATENT APPLICATION

## UTILITY PATENT APPLICATION

---

## TITLE OF THE INVENTION

**SYSTEM AND METHOD FOR DYNAMIC PHYSIOLOGICAL LAG-COMPENSATED TEMPORAL SYNCHRONIZATION OF HETEROGENEOUS BIOMARKER SIGNALS FOR PERSONALIZED NUTRITION RECOMMENDATION**

---

## CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority to Korean Patent Application No. [TO BE ASSIGNED], filed [DATE], the entire contents of which are incorporated herein by reference.

---

## STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH

Not Applicable.

---

## FIELD OF THE INVENTION

The present invention relates generally to personalized nutrition and health informatics systems, and more particularly to a computer-implemented system and method for temporally synchronizing heterogeneous biomarker data streams using a dynamic physiological lag model that incorporates genetic metabolic rate modifiers and circadian rhythm modifiers, and for generating real-time personalized nutrient budget recommendations through a multi-stage processing pipeline with adaptive self-calibration, hierarchical conflict resolution, and dynamic differential privacy protection.

---

## BACKGROUND OF THE INVENTION

### Technical Field

The present invention pertains to biomarker-driven personalized nutrition recommendation systems that integrate continuous glucose monitoring (CGM), wearable sensor data, genomic profiles, and meal event records to compute individualized nutritional guidance.

### Description of the Related Art

Existing nutrition management applications, including but not limited to MyFitnessPal, Noom, Lose It!, and Levels Health, suffer from a fundamental technical limitation: they record nutrient intake events and biomarker measurements as temporally independent observations without computing the causal time delay between them.

For example, conventional systems can simultaneously record that "300 grams of carbohydrates were consumed" and that "blood glucose was 180 mg/dL at 3:00 PM," but they are computationally incapable of inferring that "the 300 grams of carbohydrates caused the 180 mg/dL glucose reading approximately 120 minutes later."

This limitation arises because biological cause-effect relationships exhibit inherent temporal delays that vary across multiple dimensions:

**(a) Biomarker-specific delay:** Post-prandial glucose response occurs 45-120 minutes after meal ingestion (with interstitial CGM sensor delay adding ~15 minutes, resulting in total observed lag of approximately 60 minutes); heart rate autonomic response occurs within 30 seconds of stimuli; cortisol peaks 20-40 minutes after a stress event.

**(b) Genetic variation:** Individuals carrying the TCF7L2 rs7903146 T/T genotype exhibit approximately 25% longer glucose clearance times compared to C/C carriers, directly affecting the temporal lag between meal ingestion and peak glucose response.

**(c) Circadian variation:** The same individual consuming the same meal exhibits different temporal lag patterns depending on time of day. Morning insulin sensitivity (06:00-10:00) produces shorter glucose response lags (modifier 0.82-0.90), while late-night metabolic activity (00:00-04:00) produces longer lags (modifier 1.15-1.20).

**(d) Heterogeneous sampling rates:** CGM data is sampled every 5 minutes, heart rate every 1-60 seconds, sleep data once per day, and genotype data is a one-time static measurement. These fundamentally different temporal behaviors cannot be aligned through naive timestamp-based sorting or linear interpolation.

Prior art systems such as Levels Health employ machine learning black-box approaches that predict glucose responses without explicitly modeling the physiological lag mechanism. Such approaches require large training datasets, lack explainability (making regulatory approval difficult), and cannot decompose predictions into biologically meaningful components.

Apple Health aggregates multiple data sources but provides no causal temporal analysis, nutrient recommendation capabilities, or cross-signal synchronization.

No prior art system computes a personalized, time-varying physiological lag that simultaneously accounts for biomarker type, individual genotype, and circadian phase, nor provides an adaptive self-calibration mechanism that continuously refines lag predictions from observed biomarker responses.

### Technical Problem Addressed by the Present Invention

The above-described limitations of prior art systems constitute a concrete technical problem in the field of biomedical data processing: **the inability of existing computing systems to correctly temporally align heterogeneous biomarker data streams that have fundamentally different sampling rates, temporal behaviors, and physiological cause-effect delays.** This is not merely a problem of applying known mathematical operations to biological data; rather, it is a problem rooted in the architecture of how computing systems process, synchronize, and aggregate multi-source sensor data in real time.

Specifically, the technical problems addressed include:

**(i) Signal Alignment Failure:** Existing computing systems apply naive timestamp-based sorting or fixed-offset resampling to biomarker time series. This produces systematically incorrect temporal alignments because the actual causal delay varies by biomarker type (0 seconds for genotype to 8 hours for sleep cycle observation), by individual genotype (±25% or more), and by time of day (±20%). The result is that cross-signal correlation analyses in prior art systems produce Pearson correlation coefficients of approximately 0.15 — effectively noise-level — rendering the computational output unreliable for any downstream decision-making.

**(ii) Data Processing Bottleneck:** Processing heterogeneous sensor data with sampling rates ranging from 1 reading per 5 minutes (CGM) to 1 reading per day (sleep) to 1 reading per lifetime (genotype) on a unified temporal grid requires an unconventional data processing architecture. Standard time-series resampling techniques (linear interpolation, nearest-neighbor, forward-fill) are computationally inadequate because they ignore the biological meaning encoded in each signal's temporal behavior. Furthermore, base lag values span five orders of magnitude — from 0 seconds (genotype) through 30 seconds (heart rate) to 28,800 seconds (sleep) — requiring a flexible, self-describing adapter architecture rather than hard-coded resampling.

**(iii) Edge Computing Constraint:** Raw biomarker data — particularly genetic data — is too sensitive to transmit to cloud servers. The entire multi-stage pipeline must execute within the constrained computational environment of a mobile edge device while maintaining real-time responsiveness. This requires specific architectural decisions about data structure design, memory management, and computation ordering that are distinct from server-based implementations.

**(iv) Sensor Noise and Staleness:** Real-world biomarker sensors produce noisy, intermittent data. The system must distinguish between a genuinely missing signal (requiring interpolation) and a stale signal (requiring confidence degradation), and must do so differently for each sensor type based on its declared sampling characteristics. This requires a specific technical mechanism (exponential staleness decay with per-sensor half-lives) that has no analogue in general-purpose data processing.

The present invention solves these concrete technical problems through a specific, unconventional arrangement of computing steps — the seven-stage pipeline with dynamic lag compensation — that produces a measurable technical improvement: meal-to-glucose correlation improves from Pearson r ≈ 0.15 to r ≈ 0.78 (+420%), and peak timing prediction error decreases from ~45 minutes to ~8 minutes (−82%). These are improvements to the functioning of the computing system itself, not merely the application of a mathematical formula to pre-existing data.

### Objects of the Invention

It is therefore an object of the present invention to provide a system and method that computes personalized physiological lag times for heterogeneous biomarker signals by multiplying three independent biological axes: intrinsic signal lag, genetic metabolic rate, and circadian metabolic efficiency.

It is a further object of the present invention to provide an adaptive self-calibration feedback loop that automatically refines per-user lag predictions by back-propagating prediction-versus-actual errors through three independent correction channels.

It is a further object of the present invention to provide a multi-stage processing pipeline that transforms raw biomarker readings into personalized real-time nutrient budgets through physiologically-aware normalization, circadian-aware interpolation, composite metabolic state estimation, and hierarchical conflict resolution.

It is a further object of the present invention to provide a dynamic differential privacy mechanism that allocates privacy budgets based on data sensitivity tiers, ensuring that genetic data receives stronger privacy protection than activity data.

It is a further object of the present invention to provide a system that operates primarily on edge devices, ensuring that raw health data never leaves the user's device, with only privacy-protected embeddings transmitted to a server.

---

## SUMMARY OF THE INVENTION

The present invention provides a computer-implemented system and method for personalized nutrition recommendation based on dynamic physiological lag-compensated temporal synchronization of heterogeneous biomarker signals.

### Core Innovation: Dynamic Physiological Lag Model

The system computes a synchronized timestamp for each biomarker reading according to the formula:

**t_sync = t_event + Δt_base(b) × γ_genetic(g) × φ_circadian(c)**

where:

- **Δt_base(b)** is an intrinsic physiological lag specific to biomarker type b, representing the inherent cause-effect delay of the biological signal (e.g., 60 minutes for interstitial glucose response to meal ingestion accounting for digestion, absorption, and interstitial equilibration; 30 seconds for heart rate autonomic response; 20 minutes for step count aggregation reflecting accelerometer processing latency; 5 minutes for HRV parasympathetic modulation; 8 hours for sleep data reflecting full sleep cycle observation);

- **γ_genetic(g)** is a genetic metabolic rate modifier derived from the user's Single Nucleotide Polymorphism (SNP) profile, computed as the geometric mean of inverse metabolic modifier coefficients for all SNPs affecting the given biomarker, clamped to the range [0.5, 2.0], such that a TCF7L2 rs7903146 T/T carrier has γ = 1.25 indicating 25% slower glucose clearance;

- **φ_circadian(c)** is a circadian rhythm modifier representing time-of-day metabolic efficiency, ranging from 0.82 (morning peak insulin sensitivity, faster response) to 1.20 (late-night nadir, slower response), with sub-hour linear interpolation for smooth transitions.

### Adaptive Self-Calibration Feedback Loop

The static lag formula is extended into a self-evolving model through an adaptive calibration mechanism:

**t_sync_cal = t_event + (Δt_base(b) + δ_base(b)) × (γ_genetic(g) × κ_genetic) × (φ_circadian(c) + δ_circ(h))**

Three independent correction channels back-propagate prediction-versus-actual peak timing errors:

- **δ_base(b):** an additive per-biomarker base lag offset, clamped to ±1,800 seconds;
- **κ_genetic:** a multiplicative genetic coefficient correction, clamped to [0.5, 1.5];
- **δ_circ(h):** an additive per-hour circadian phase correction, clamped to ±0.3.

Each channel uses an Exponential Moving Average (EMA) with adaptive learning rates that decay according to α(k) = α₀ / (1 + k/τ), where τ = 20, enabling fast initial adaptation followed by stable convergence.

### Seven-Stage Processing Pipeline

The system processes biomarker data through a seven-stage pipeline, each stage dependent on the preceding stage's output:

- **Stage 0 (Consent Filter):** Dynamic consent enforcement at the algorithm level, physically removing non-consented biomarker types before any computation occurs;
- **Stage 1 (Temporal Synchronization):** Dynamic lag-compensated alignment of all signals onto a unified multi-resolution temporal grid;
- **Stage 2 (Physiological Normalization):** Genetic baseline-aware Z-score computation using individual genotype-adjusted reference ranges rather than population averages, with a priority cascade that prefers a mature personal baseline (≥50 samples) over genetic baseline, and genetic baseline over population defaults;
- **Stage 3 (Circadian Interpolation):** Data gap filling using a dual-component circadian rhythm model with circadian (24-hour) and ultradian (90-minute) oscillations;
- **Stage 4 (Metabolic State Estimation):** Composite metabolic state classification across 14 simultaneous phases, with HRV-based sleep quality estimation affecting insulin sensitivity;
- **Stage 4.5 (Context-Aware Re-Normalization):** Selective re-normalization of signals using confirmed metabolic context from Stage 4;
- **Stage 5 (Nutrient Demand Calculation):** Real-time personalized nutrient budget computation with hierarchical conflict resolution between genetic optimization and medical safety constraints;
- **Stage 6 (Differential Privacy Noise Injection):** Dynamic epsilon allocation based on four-tier data sensitivity classification.

### Hierarchical Conflict Resolution

When genetically-optimized nutrient targets conflict with medical safety thresholds, the system applies a six-level priority hierarchy: Medical Critical (priority 5, never overridable) > Medical Warning (4) > Genetic Optimization (3) > Biomarker Reactive (2) > Metabolic State (1) > Base RDA (0). Complete audit trails are generated for every conflict resolution, including conflict type, winner, loser, safety margin, and human-readable rationale.

### Privacy Architecture

The system implements triple-layer privacy protection: (1) edge computing where all raw data processing occurs on-device; (2) dynamic differential privacy with four sensitivity tiers (CRITICAL ε=0.1 for genetic data, HIGH ε=0.3 for glucose, MEDIUM ε=0.5 for heart rate/sleep, LOW ε=0.8 for activity); and (3) dynamic consent management with 15 granular consent scopes and immediate revocation propagation.

### Specific Technical Improvements Over Prior Art (35 U.S.C. § 101 Compliance)

The present invention is not directed to an abstract idea, a law of nature, or a natural phenomenon. Rather, it provides **specific technical improvements to the functioning of a computer system** that processes heterogeneous biomedical sensor data. The claimed invention satisfies the requirements of 35 U.S.C. § 101 under the Alice/Mayo framework for the following reasons:

**(A) The Invention Improves Computer Functionality Itself (Enfish-Type Improvement):**

The dynamic physiological lag model fundamentally improves how a computing system aligns and processes multi-source sensor data streams. Prior art systems process each biomarker as an independent time series with fixed temporal offsets. The present invention's three-axis multiplicative lag model (Δt_base × γ_genetic × φ_circadian) constitutes an unconventional technical solution that enables the computing system to produce temporally coherent cross-signal representations from inherently asynchronous sensor inputs. This is analogous to the self-referential database table in *Enfish, LLC v. Microsoft Corp.* (Fed. Cir. 2016), which improved how a computer stores and retrieves data rather than merely using a computer to perform a known task.

**Quantified improvement:** The system transforms meal-to-glucose Pearson correlation from r ≈ 0.15 (noise-level, computationally useless) to r ≈ 0.78 (strong, computationally actionable) — a 420% improvement in the accuracy of the computer system's data processing output.

**(B) The Invention Is Tied to Specific, Interoperating Hardware Components (Machine-or-Transformation Test):**

The claims are not directed to mathematical formulas applied in the abstract. They require a specific configuration of interoperating physical hardware components that collectively form a special-purpose biomarker processing machine:

**(B.1) Biomarker Sensor Hardware:** A continuous glucose monitor (CGM) physically attached to the user's body via a subcutaneous filament, producing interstitial glucose readings at approximately 5-minute intervals through electrochemical sensing; wearable photoplethysmography (PPG) and electrocardiography (ECG) sensors for heart rate and HRV measurement; accelerometers for step count and sleep detection.

**(B.2) Edge Computing Processor with Secure Enclave:** An ARM-based mobile system-on-chip (SoC) executing the complete seven-stage pipeline within a 500ms latency budget, with a hardware-isolated Trusted Execution Environment (TEE) or Secure Enclave for genetic data processing. The pipeline's computational requirements — simultaneous processing of 5+ concurrent sensor streams, real-time peak detection with EMA smoothing, three-channel error back-propagation, and dynamic privacy budget tracking — necessitate dedicated floating-point processing hardware that precludes mental execution or pen-and-paper calculation.

**(B.3) Non-Transitory Persistent Storage:** Flash memory storing per-user calibration profiles that persist across power cycles. The self-improving nature of the system (Claim 2) fundamentally depends on this physical storage — without it, the three correction channels (δ_base, κ_genetic, δ_circ) cannot accumulate learned adjustments across sessions, and the system cannot converge from 45-minute MAE to 8-minute MAE.

**(B.4) Hardware-Enforced Privacy Boundary:** A network interface with cryptographic schema validation that physically prevents raw biomarker data from leaving the device. This is not a software access control — it is an architectural constraint where the network stack itself validates outgoing payloads against a whitelist schema, making privacy protection a hardware-level guarantee rather than a policy-level promise.

**(B.5) Real-Time Sensor Fusion Requirement:** The claimed method requires concurrent, real-time data ingestion from multiple physically distinct sensors (CGM via BLE, wearable via BLE, genetic data from secure storage) with different sampling rates (5 min, 30 sec, one-time), different temporal behaviors (CONTINUOUS, EVENT, PERIODIC, STATIC), and different physical measurement modalities (electrochemical, optical, mechanical, molecular). This multi-modal real-time sensor fusion cannot be performed mentally, on paper, or through generic computer implementation — it requires specific sensor hardware, communication protocols, and processing architecture.

Under *In re Alappat*, 33 F.3d 1526 (Fed. Cir. 1994), a general-purpose computer programmed to perform specific functions constitutes a "new machine." The present invention's edge device, programmed with the seven-stage pipeline and coupled to specific biomarker sensors, constitutes a special-purpose biomarker temporal synchronization machine that did not exist in the prior art.

**(C) The Ordered Combination of Steps Is Unconventional (BASCOM-Type Analysis):**

While individual mathematical operations (multiplication, averaging, decay functions) may be conventional in isolation, the specific ordered combination of seven processing stages — consent filtering → lag-compensated synchronization → genotype-aware normalization → circadian interpolation → composite metabolic state estimation → context-aware re-normalization → hierarchical conflict resolution with medical safety enforcement → dynamic differential privacy — constitutes an unconventional arrangement that produces a result not achievable by any prior art system. Each stage's output transforms the input for the subsequent stage in a physiologically-constrained sequence that cannot be reordered without breaking biological correctness.

**(D) The Adaptive Self-Calibration Feedback Loop Creates a Self-Improving Machine:**

The three-channel error back-propagation mechanism (δ_base, κ_genetic, δ_circ) with adaptive learning rate decay transforms a static computing model into a self-improving system. This is not a mathematical abstraction — it requires persistent storage of per-user calibration profiles across computing sessions, real-time peak detection in streaming sensor data, and coordinated updates across three independent correction channels. The result is a computing system whose temporal alignment accuracy autonomously improves over time without human intervention, from an initial peak timing error of ~45 minutes to ~8 minutes after calibration.

**(E) The Invention Produces a Concrete, Tangible Result:**

The output of the system is not an abstract mathematical value. It is a structured **NutrientBudget** — a concrete data artifact comprising 14 specific nutrient targets allocated across temporal windows, with a complete audit trail of every modification, conflict resolution, and privacy transformation. This tangible output directly controls the information displayed to the user on a physical device screen and can be transmitted to downstream systems (food ordering, meal planning) for automated actuation.

**(F) Edge-Cloud Architecture Provides Specific Technical Security Improvement:**

The system's triple-layer privacy architecture (edge computing + dynamic differential privacy + consent management) solves a specific technical problem in distributed computing: how to provide personalized recommendations derived from highly sensitive biomedical data without transmitting that data to a server. The four-tier dynamic epsilon allocation and Privacy Exposure Index tracking constitute specific technical mechanisms that improve the security of the computing system, not merely the application of known privacy techniques to a new data type.

---
## BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the principles of the invention.

**FIG. 1** is a high-level system architecture diagram showing the edge-cloud separation, biomarker source adapters, the seven-stage processing pipeline, and privacy boundary.

**FIG. 2** is a detailed flowchart of the Dynamic Physiological Lag Model showing the three-axis multiplication (base lag × genetic modifier × circadian modifier) for computing personalized synchronized timestamps.

**FIG. 3** is a data flow diagram of the seven-stage processing pipeline (Stage 0 through Stage 6) showing inter-stage dependencies and data transformations.

**FIG. 4** is a block diagram of the Adaptive Self-Calibration Feedback Loop showing the three correction channels (δ_base, κ_genetic, δ_circ), peak detection, error back-propagation, and adaptive learning rate decay.

**FIG. 5** is a graph illustrating circadian lag modifier values over a 24-hour period, showing morning metabolic peak (0.82) and late-night nadir (1.20).

**FIG. 6** is a diagram showing the Hierarchical Conflict Resolution Layer with six priority levels and example conflict scenarios between genetic optimization and medical safety constraints.

**FIG. 7** is a flowchart of the Dynamic Epsilon Differential Privacy system showing four sensitivity tiers, adaptive budget allocation, and Privacy Exposure Index tracking.

**FIG. 8** is a comparative chart showing correlation improvement between raw temporal alignment (Pearson r ≈ 0.15) and lag-compensated alignment (Pearson r ≈ 0.78) for meal-to-glucose events.

**FIG. 9** is a block diagram of the Physiological Normalization module showing the five-step normalization pipeline: circadian correction, personal Z-score, context-dependent scaling, genetic modifier weighting, and anomaly scoring.

**FIG. 10** is a diagram of the Composite Metabolic State Estimation showing 14 simultaneous metabolic phases across four categories (dietary, exercise, sleep, stress) and their multiplicative nutrient priority shifts.

---

### DETAILED DRAWING SPECIFICATIONS

The following detailed specifications are provided for preparation of formal patent drawings conforming to 37 C.F.R. § 1.84.

#### FIG. 1 — System Architecture Diagram

**Drawing type:** Block diagram (landscape orientation recommended)

**Layout:** Two large rectangular regions separated by a thick dashed vertical line labeled **"PRIVACY BOUNDARY (102)"** spanning the full height of the drawing.

**Left region — EDGE DEVICE (100):**

- Top row: Five sensor blocks arranged horizontally, each drawn as a rounded rectangle with an antenna icon:
  - **(110) CGM Adapter** — labeled "CGM Sensor / BLE 5.0 / CONTINUOUS / Δt=3,600s"
  - **(112) Activity Adapter** — labeled "Wearable HR+HRV / BLE 5.0 / CONTINUOUS / Δt=30s"
  - **(114) Sleep Adapter** — labeled "Sleep Tracker / BLE / PERIODIC / Δt=28,800s"
  - **(116) Genetic Adapter** — labeled "SNP Genotype / NFC Import / STATIC / Δt=0"
  - **(118) Location Adapter** — labeled "GPS+Environment / PERIODIC / Δt=1,800s"

- Below sensors: Arrow lines merge into a single bus labeled **"BiomarkerReading Stream (120)"** containing the text: "source_id, user_id, type, timestamp, value, unit, confidence, metadata, raw_hash"

- Center of left region: A vertical stack of eight processing blocks connected by downward arrows forming the **Pipeline (130)**. Each block is a rectangle with stage number:
  - **(130-0) Stage 0: Consent Filter** — icon: shield
  - **(130-1) Stage 1: Temporal Sync** — icon: clock with arrows; formula "t_sync = t_event + Δt × γ × φ" shown adjacent
  - **(130-2) Stage 2: Normalization** — icon: bell curve
  - **(130-3) Stage 3: Interpolation** — icon: sine wave
  - **(130-4) Stage 4: Metabolic State** — icon: gauge/meter
  - **(130-4.5) Stage 4.5: Re-Normalization** — icon: refresh arrows
  - **(130-5) Stage 5: Nutrient Calc** — icon: scale/balance
  - **(130-6) Stage 6: DP Noise** — icon: lock with noise waves

- Bottom-left: Rectangle labeled **"Secure Enclave / TEE (140)"** with a lock icon, connected by a bidirectional arrow to Stage 1 (for genetic modifier computation) and Stage 6 (for privacy operations).

- Bottom-center: Cylinder labeled **"Persistent Storage (142)"** — contents: "Calibration Profiles (δ_base, κ_genetic, δ_circ), Personal Baselines, Consent State"

- A feedback arrow from Stage 1 output loops back through an **"Adaptive Calibration Loop (144)"** block returning to Stage 1 input.

**Right region — SERVER / CLOUD (200):**

- Small input block **(202)** labeled "Incoming: 64-dim embedding + DP-noised stats + metabolic labels"
- Processing block **(210)** labeled "HL7 FHIR R4 Server / Recommendation Engine"
- Output block **(220)** labeled "Personalized Dietary Recommendations"
- Database cylinder **(230)** labeled "De-identified Population Analytics"
- Block **(240)** labeled "EHR / HIE Integration (FHIR RESTful API)"

**Arrows crossing privacy boundary (102):** Exactly three arrows from left to right:
  1. Arrow labeled "64-dim Feature Embedding"
  2. Arrow labeled "DP-Protected Statistics (ε-noised)"
  3. Arrow labeled "Categorical State Labels"

A large **X** symbol over a crossed-out arrow labeled "RAW DATA" to visually emphasize that raw biomarker data cannot cross the boundary.

**Reference numerals:** 100, 102, 110, 112, 114, 116, 118, 120, 130, 130-0 through 130-6, 140, 142, 144, 200, 202, 210, 220, 230, 240.

---

#### FIG. 2 — Dynamic Physiological Lag Model Flowchart

**Drawing type:** Detailed flowchart (portrait orientation)

**Start:** Rounded rectangle **(300)** labeled "Receive BiomarkerReading (type b, timestamp t_event, user g)"

**Step 1 — (310):** Decision diamond: "Is biomarker type STATIC?" → Yes: rectangle **(312)** "lag = 0, skip lag computation" → proceed to End. No: continue.

**Step 2 — (320):** Rectangle: "Look up Δt_base(b) from SamplingCharacteristics" with adjacent table:
```
GLUCOSE: 3,600s | HR: 30s | HRV: 300s | STEPS: 1,200s | SLEEP: 28,800s
```

**Step 3 — (330):** Rectangle: "Retrieve user's SNP profile for biomarker type b"

**Step 4 — (340):** Rectangle: "Compute γ_genetic = exp((1/k) × Σ ln(1/mᵢ))" with annotation: "Geometric mean of inverse modifiers"

**Step 5 — (345):** Rectangle: "Clamp γ_genetic to [0.5, 2.0]"

**Step 6 — (350):** Rectangle: "Extract hour h from t_event"

**Step 7 — (360):** Rectangle: "Look up φ_circadian from 24-hour table" with small embedded graph showing the 0.82-1.20 curve

**Step 8 — (365):** Rectangle: "Sub-hour interpolation: φ(t) = φ_h + (φ_{h+1} − φ_h) × (min/60)"

**Step 9 — (370):** Large bold rectangle with multiplication symbol: **"t_sync = t_event + Δt_base × γ_genetic × φ_circadian"**

**Step 10 — (380):** Decision diamond: "Calibration profile exists?" → Yes: rectangle **(382)** "Apply corrections: t_sync_cal = t_event + (Δt + δ_base) × (γ × κ) × (φ + δ_circ)" → No: use uncalibrated t_sync.

**End:** Rounded rectangle **(390)** "Output: LagComputation(base_lag, genetic_modifier, circadian_modifier, effective_lag, t_sync)"

**Reference numerals:** 300, 310, 312, 320, 330, 340, 345, 350, 360, 365, 370, 380, 382, 390.

---

#### FIG. 3 — Seven-Stage Pipeline Data Flow Diagram

**Drawing type:** Horizontal swimlane diagram (landscape orientation)

**Seven horizontal swimlanes** stacked vertically, each labeled with stage number and name. Arrows flow left-to-right within lanes and downward between lanes.

**Swimlane 0 — Consent Filter (400):**
- Input: "Raw BiomarkerReadings[]" → Process: "Check BIOMARKER_CONSENT_MAP" → Decision: "Consented?" → Yes: pass through → No: "Remove from stream" (red X). Side output: "If !GENETIC_DATA consent → γ = 1.0"
- Output: "Filtered BiomarkerReadings[]"

**Swimlane 1 — Temporal Sync (410):**
- Input: Filtered readings → Process: "PhysiologicalLagModel.compute_lag()" → Process: "TemporalSynchronizer.build_frame()" → Three nested processes: "FINE (5min) / MEDIUM (1hr) / COARSE (24hr)"
- Output: "SynchronizedFrame{signals, confidences, completeness}"

**Swimlane 2 — Normalization (420):**
- Input: SynchronizedFrame → Five sequential sub-blocks: "(1) Circadian Correct → (2) Z-score (Personal→Genetic→Pop) → (3) Context Scale → (4) Genetic Weight → (5) Anomaly Score"
- Output: "NormalizedSignal{z_score, context_factor, anomaly, confidence}"

**Swimlane 3 — Interpolation (430):**
- Input: NormalizedSignals → Process: "CircadianInterpolator: c(t) = baseline × (1 + A_c cos + A_u cos)" → Blend: "r = sigmoid(gap) → (1-r)×neighbor + r×circadian"
- Output: "Complete signal grid (no gaps)"

**Swimlane 4 — Metabolic State (440):**
- Input: Complete signals → Four parallel detection paths: "Dietary (meal timing) | Exercise (HR>100) | Sleep (steps<5) | Stress (HRV<30 / >60)" → Merge: "14-phase composite MetabolicState"
- Side process: "Sleep Quality = 0.6×HRV_q + 0.4×Dur_q" → "Insulin Sensitivity Penalty"
- Output: "MetabolicState{phases[], intensities, sleep_quality, insulin_sensitivity}"

**Swimlane 4.5 — Re-Normalization (445):**
- Input: Stage 4 MetabolicState + Stage 2 NormalizedSignals → Decision: "|old_factor − new_factor| > 0.01?" → Yes: "Re-normalize with confirmed context" → No: "Keep existing"
- Output: "Updated NormalizedSignals"

**Swimlane 5 — Nutrient Calc (450):**
- Input: All prior stages → Eight sequential steps: "(1) Base RDA → (2) Metabolic Mods → (3) Genetic Mods → (4) Biomarker Reactive → (5) Consumption Deduct → (6) Conflict Resolve → (7) Time Bucket → (8) Output"
- Side block: "Hierarchical Conflict Resolution (priority 0-5)" with audit trail output
- Output: "NutrientBudget{targets[14], buckets[], audit_trail[], conflicts[]}"

**Swimlane 6 — DP Noise (460):**
- Input: NutrientBudget → Process: "Classify sensitivity tier (CRITICAL/HIGH/MEDIUM/LOW)" → Process: "DynamicEpsilonAllocator: ε × α(budget)" → Process: "Inject Laplace/Gaussian noise"
- Side block: "PEI tracker: ε_consumed / ε_total"
- Output: "Privacy-Protected NutrientBudget + 64-dim Embedding"

**Reference numerals:** 400, 410, 420, 430, 440, 445, 450, 460.

---

#### FIG. 4 — Adaptive Self-Calibration Feedback Loop

**Drawing type:** Block diagram with feedback arrows (landscape orientation)

**Top section — Forward Path (500):**
- Block **(502):** "Meal/Exercise Event (trigger)" → Arrow to Block **(504):** "Physiological Lag Model (with current calibration)" → Arrow labeled "Predicted peak time t_pred" to Block **(506):** "Wait for observation window"

**Middle section — Peak Detection (510):**
- Block **(506)** feeds into Block **(512):** "PeakDetector" containing four sequential sub-blocks:
  - "(1) EMA Smoothing (α=0.3)"
  - "(2) Local Maximum Detection"
  - "(3) Prominence Filter (>10% range)"
  - "(4) Highest-prominence selection"
- Output: "Detected actual peak time t_actual, confidence"

**Error Computation (520):**
- Block **(522):** "ε = t_actual − t_pred" (error computation)
- Three arrows fan out from (522) labeled "Channel 1," "Channel 2," "Channel 3"

**Bottom section — Three Correction Channels (530):**

Three parallel channel blocks arranged horizontally:

- **(532) Channel 1 — Base Lag Offset:**
  - Formula: "δ_base^(k+1) = (1−α) × δ_base^(k) + α × ε"
  - Annotation: "α₀ = 0.3, clamp ±1,800s"
  - Small graph: decaying learning rate curve

- **(534) Channel 2 — Circadian Phase:**
  - Formula: "δ_circ^(k+1) = (1−α) × δ_circ^(k) + α × (ε/lag)"
  - Annotation: "α₀ = 0.2, clamp ±0.3"

- **(536) Channel 3 — Genetic Coefficient:**
  - Formula: "κ^(k+1) = (1−α) × κ^(k) + α × (1+ε_rel)"
  - Annotation: "α₀ = 0.1, clamp [0.5, 1.5]"

**Learning Rate Schedule (540):**
- Single formula block: "α(k) = α₀ / (1 + k/τ), τ = 20"
- Small graph showing exponential decay from α₀ to near-zero

**Convergence Check (550):**
- Decision diamond: "obs ≥ 10 AND score > 0.8?"
- Formula shown: "score = 0.6 × improvement + 0.4 × stability"
- Yes → "Converged: reduce learning rate" / No → "Continue calibrating"

**Feedback Arrow (560):**
- Large curved arrow from (530) channel outputs back to (504) "Lag Model," passing through:
  - Cylinder **(562):** "Persistent Calibration Store (Flash Memory)"
  - Label on arrow: "Updated δ_base, κ_genetic, δ_circ written to non-volatile storage"

**Reference numerals:** 500, 502, 504, 506, 510, 512, 520, 522, 530, 532, 534, 536, 540, 550, 560, 562.

---

#### FIG. 5 — Circadian Lag Modifier 24-Hour Profile

**Drawing type:** Line graph with data points (landscape orientation)

**Axes:**
- X-axis: "Hour of Day (00:00 – 23:00)" with tick marks at each hour
- Y-axis: "φ_circadian (Lag Modifier)" ranging from 0.75 to 1.25, with reference line at 1.0 labeled "Baseline"

**Data points (all 24 hours):** Connected by smooth curve with filled circular markers:
```
(0, 1.15), (1, 1.18), (2, 1.20), (3, 1.18), (4, 1.10), (5, 1.00),
(6, 0.90), (7, 0.85), (8, 0.82), (9, 0.85), (10, 0.88), (11, 0.90),
(12, 0.92), (13, 0.95), (14, 0.98), (15, 1.00), (16, 1.02), (17, 1.05),
(18, 1.03), (19, 1.00), (20, 1.05), (21, 1.08), (22, 1.10), (23, 1.12)
```

**Annotations:**
- Arrow pointing to (8, 0.82): **"Morning Peak: φ = 0.82 — Shortest lag (highest insulin sensitivity)"**
- Arrow pointing to (2, 1.20): **"Circadian Nadir: φ = 1.20 — Longest lag (lowest metabolic rate)"**
- Shaded region (06:00–10:00) in light green: labeled "Optimal Metabolic Window"
- Shaded region (00:00–04:00) in light red: labeled "Metabolic Nadir Zone"
- Horizontal dashed line at 1.0: "Baseline Reference (15:00 = 1.00)"

**Inset box** (upper right): "Effect on 60-minute glucose lag:"
- "At 08:00: 60 × 0.82 = 49.2 min"
- "At 02:00: 60 × 1.20 = 72.0 min"
- "Δ = 22.8 min (46% variation)"

**Reference numerals:** 600 (graph), 602 (morning peak annotation), 604 (nadir annotation), 606 (optimal zone), 608 (nadir zone), 610 (inset).

---

#### FIG. 6 — Hierarchical Conflict Resolution Layer

**Drawing type:** Layered pyramid/stack diagram with example flow (portrait orientation)

**Main element — Priority Pyramid (700):**
Six horizontal layers stacked vertically, widest at bottom, narrowest at top. Each layer colored with increasing intensity toward top:

- **(706) Priority 5 — Medical Critical** (top, dark red): "NEVER overridable — CKD, severe allergies, drug interactions"
- **(705) Priority 4 — Medical Warning** (orange): "NEVER overridable — Hypertension, diabetes thresholds"
- **(704) Priority 3 — Genetic Optimization** (blue): "Overridable by medical — SNP-based nutrient efficiency"
- **(703) Priority 2 — Biomarker Reactive** (green): "Overridable — Real-time Z-score adjustments"
- **(702) Priority 1 — Metabolic State** (light green): "Overridable — Phase-specific modifiers"
- **(701) Priority 0 — Base RDA** (gray, bottom): "Overridable — Population defaults"

**Right side — Example Conflict Flow (720):**

Flow diagram showing a concrete conflict scenario:

1. Box **(722):** "Genetic: ACE D/D → Protein ×1.5 = 126g"
2. Box **(724):** "Medical: CKD Stage 3 → Protein ≤ 56g" (red border)
3. Comparison block **(726):** "126g > 56g → CONFLICT DETECTED"
4. Resolution block **(728):** "Priority 5 > Priority 3 → Medical WINS"
5. Output block **(730):** "Resolved: Protein = 56g"
6. Audit record block **(732):** Shows ConflictResolution structure:
```
{nutrient: "protein_g",
 conflict_type: "genetic_vs_medical",
 genetic_recommended: 126.0,
 medical_limit: 56.0,
 resolved: 56.0,
 winner: "medical_critical",
 loser: "genetic",
 rationale: "CKD stage 3 requires protein ≤56g"}
```

**Reference numerals:** 700, 701-706, 720, 722, 724, 726, 728, 730, 732.

---

#### FIG. 7 — Dynamic Epsilon Differential Privacy System

**Drawing type:** Flowchart with state machine (landscape orientation)

**Input (800):** Rectangle: "NutrientBudget from Stage 5 (14 nutrient targets)"

**Step 1 — Tier Classification (810):**
Four-column classification table:
```
CRITICAL (ε=0.1): Genetic data, rare conditions
HIGH     (ε=0.3): Glucose, blood tests, medications
MEDIUM   (ε=0.5): Heart rate, HRV, sleep
LOW      (ε=0.8): Steps, exercise, activity
```

**Step 2 — Budget Check (820):**
State machine with three states connected by arrows:
- **(822) Normal** (green): "Budget < 70% → α = 1.0 (full ε)"
- **(824) Warning** (yellow): "70% ≤ Budget < 90% → α = 0.75 (reduced ε)"
- **(826) Critical** (red): "Budget ≥ 90% → α = 0.5 (minimum ε)"
- Arrows between states labeled with budget consumption thresholds

**Step 3 — Noise Computation (830):**
Two parallel paths:
- **(832) Laplace Mechanism:** "ṽ = v + Lap(Δ / (ε_tier × α))" — for pure ε-DP
- **(834) Gaussian Mechanism:** "ṽ = v + N(0, σ²)" where "σ = sensitivity × √(2ln(1.25/δ)) / ε" — for (ε,δ)-DP

**Step 4 — PEI Tracking (840):**
Gauge/meter visualization:
- Semicircular gauge from 0.0 to 1.0
- Four colored zones: Green (0–0.39 "Low"), Yellow (0.4–0.69 "Moderate"), Orange (0.7–0.89 "High"), Red (0.9–1.0 "Critical")
- Formula: "PEI = Σε_consumed / ε_total"

**Step 5 — Reset (850):**
Clock icon with "24-hour reset cycle: ε_total = 1.0, δ = 10⁻⁵"

**Output (860):** "Privacy-Protected NutrientBudget + Privacy Exposure Report"

**Reference numerals:** 800, 810, 820, 822, 824, 826, 830, 832, 834, 840, 850, 860.

---

#### FIG. 8 — Temporal Alignment Correlation Improvement (KEY EVIDENTIARY FIGURE)

**Drawing type:** Dual-panel comparative scatter plot with bar chart summary (landscape orientation)

**This figure constitutes the primary quantitative evidence of technical improvement and should be prominently referenced in any Office Action response regarding 35 U.S.C. § 101 eligibility.**

**Panel A — Left (900): "Before: Raw Timestamp Alignment"**
- Scatter plot with:
  - X-axis: "Meal Event Time (minutes)" [0 to 300]
  - Y-axis: "Glucose Peak Response (mg/dL)" [80 to 250]
  - ~50 data points scattered with no clear pattern (random cloud)
  - Regression line: nearly flat, shallow slope
  - Annotation box: **"Pearson r = 0.15 (p > 0.1) — Noise-level correlation"**
  - Large red "✗" watermark: "COMPUTATIONALLY USELESS"

**Panel B — Right (910): "After: Lag-Compensated Alignment"**
- Scatter plot with same axes:
  - ~50 data points showing clear positive linear trend
  - Regression line: steep positive slope with narrow confidence band
  - Annotation box: **"Pearson r = 0.78 (p < 0.001) — Strong correlation"**
  - Large green "✓" watermark: "COMPUTATIONALLY ACTIONABLE"

**Panel C — Bottom center (920): Summary Bar Chart**
- Three grouped bar pairs comparing Before (gray) vs. After (blue):
  - Bar 1: "Pearson r" — 0.15 vs. 0.78 (+420%)
  - Bar 2: "Peak Timing MAE" — 45 min vs. 8 min (−82%)
  - Bar 3: "Causal Event Match" — 0/15 vs. 14/15 (93%)
- Delta labels above each pair: "+420%", "−82%", "+93%"

**Panel D — Bottom right (930): Timing Error Distribution**
- Two overlapping histograms:
  - Gray histogram: "Before" — wide distribution centered at ~45 min, spread 10–90 min
  - Blue histogram: "After" — narrow distribution centered at ~8 min, spread 2–15 min
  - Vertical dashed line at 15 min labeled "Clinical Relevance Threshold"
  - Annotation: "After calibration: 93% of predictions within clinically relevant window"

**Caption text (recommended for formal filing):**
"FIG. 8 demonstrates the concrete, measurable technical improvement achieved by the dynamic physiological lag-compensated temporal synchronization of the present invention. Panel A shows that prior art timestamp-based sorting produces effectively random cross-signal correlation (r = 0.15). Panel B shows that the claimed lag compensation method produces strong, statistically significant correlation (r = 0.78, p < 0.001). This 420% improvement in data processing accuracy constitutes an improvement to the functioning of the computing system itself under *Enfish v. Microsoft Corp.* (Fed. Cir. 2016)."

**Reference numerals:** 900, 910, 920, 930.

---

#### FIG. 9 — Physiological Normalization Pipeline

**Drawing type:** Horizontal pipeline block diagram (landscape orientation)

**Input (1000):** "Raw Biomarker Value (v_raw)" with example: "glucose = 108 mg/dL at 07:00"

**Step 1 — (1010) Circadian Correction:**
- Block showing: "v_adjusted = v_raw − circadian_offset(hour)"
- Side annotation: circadian profile lookup (personal if mature, else population)
- Example: "108 − (+3.2) = 104.8"

**Step 2 — (1020) Personal Z-Score:**
- Three-tier decision tree:
  - "(A) Mature personal baseline (≥50 samples)?" → Yes: use personal μ, σ
  - "(B) Genetic baseline (confidence > 0.3)?" → Yes: use μ_genetic, σ_genetic
  - "(C) Fallback: Population baseline" → use μ_pop, σ_pop
- Z-score computation: "z = (v_adjusted − μ_ref) / σ_ref"
- Example fork: "Genetic: z = (104.8 − 106) / 12 = −0.10" vs. "Population: z = (104.8 − 100) / 15 = +0.32"

**Step 3 — (1030) Context-Dependent Scaling:**
- Context lookup table showing scaling factors:
  - "Postprandial → ×0.7 | Sleeping → ×1.2 | Exercising → ×0.8 | Fasting → ×1.0"
- "z_context = z × context_factor"

**Step 4 — (1040) Genetic Modifier Weighting:**
- "Apply SNP-derived modifier weight to Z-score"
- "z_weighted = z_context × genetic_factor"

**Step 5 — (1050) Anomaly Score:**
- Formula: "anomaly = 1 − exp(−0.5 × z²)"
- Small graph: exponential curve from 0 (z=0) to ~1 (high z)

**Output (1060):** "NormalizedSignal{z_score, context_factor, anomaly_score, confidence, genetic_z, population_z}"

**Reference numerals:** 1000, 1010, 1020, 1030, 1040, 1050, 1060.

---

#### FIG. 10 — Composite Metabolic State Estimation

**Drawing type:** Four-quadrant matrix with phase activation diagram (landscape orientation)

**Main structure — Four-Category Matrix (1100):**

Four labeled columns, each containing its metabolic phases as rounded rectangles:

**Column 1 — Dietary (1110):**
- **(1111)** POSTPRANDIAL_EARLY (0–2h) — intensity bar showing decay
- **(1112)** POSTPRANDIAL_LATE (2–4h)
- **(1113)** POST_ABSORPTIVE (4–12h)
- **(1114)** FASTING (≥12h) — intensity bar showing increase
- Detection signal: "Meal timestamp → hours_since_meal"

**Column 2 — Exercise (1120):**
- **(1121)** PRE_EXERCISE* (extension point, dashed border)
- **(1122)** DURING_EXERCISE (HR > 100 bpm)
- **(1123)** RECOVERY_IMMEDIATE (0–2h post)
- **(1124)** RECOVERY_DELAYED (2–48h, high/extreme intensity)
- Detection signal: "Heart rate + exercise history"

**Column 3 — Sleep (1130):**
- **(1131)** PRE_SLEEP
- **(1132)** SLEEPING (steps < 5)
- **(1133)** POST_WAKING (0–1h)
- Detection signal: "Step count + time of day"

**Column 4 — Stress/Recovery (1140):**
- **(1141)** METABOLIC_STRESS (HRV < 30ms)
- **(1142)** RECOVERY (HRV > 60ms)
- **(1143)** CIRCADIAN_LOW* (extension point, dashed border)
- Detection signal: "HRV amplitude"

**Bottom section — Composite State Engine (1150):**
- Shows that multiple phases from different columns can be simultaneously active
- Example composite: "FASTING (1114) + SLEEPING (1132) + RECOVERY (1142)" → combined nutrient modifiers shown in table:
  - Carbs: 0.8 × 1.0 × 1.2 = 0.96×
  - Protein: 1.0 × 0.8 × 1.3 = 1.04×
  - Water: 0.7 × 0.7 × 1.1 = 0.54×

**Right side — Sleep Quality Sub-Model (1160):**
- Two input signals merge into weighted average:
  - "HRV Signal → 4-tier piecewise → hrv_quality (weight: 0.6)"
  - "Duration → 5-tier piecewise → dur_quality (weight: 0.4)"
  - "sleep_quality = 0.6 × hrv_q + 0.4 × dur_q"
- Arrow to: "If quality < 0.7 → Insulin Penalty = 0.12 × (1 − q/0.7)"

**Reference numerals:** 1100, 1110-1114, 1120-1124, 1130-1133, 1140-1143, 1150, 1160.

---

## DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The following detailed description refers to the accompanying drawings. The same reference numbers in different drawings identify the same or similar elements. The following detailed description does not limit the invention. Instead, the scope of the invention is defined by the appended claims.

### 1. System Architecture Overview (FIG. 1)

Referring to FIG. 1, the system comprises two primary computing environments separated by a privacy boundary:

**(a) Edge Device (User Device):** A mobile computing device (smartphone, tablet, or dedicated health processor) that hosts the complete seven-stage processing pipeline. Raw biomarker data from continuous glucose monitors (CGMs), wearable sensors (smartwatches), and genetic test results is ingested exclusively on this device. The pipeline processes raw data through all seven stages and outputs only: (i) a fixed-size 64-dimensional feature embedding, (ii) differential-privacy-protected aggregate statistics, and (iii) categorical metabolic state labels (e.g., "fasting," "recovery"). No raw health values cross the privacy boundary.

The edge device is characterized by the following specific hardware configuration requirements:

- **Processor:** ARM-based mobile SoC (e.g., Apple A-series, Qualcomm Snapdragon, Samsung Exynos) or equivalent x86 mobile processor capable of executing floating-point matrix operations for the seven-stage pipeline within a 500-millisecond latency budget per pipeline invocation;
- **Memory:** Minimum 256 MB dedicated working memory for pipeline execution, accommodating: per-user calibration profiles (~12 KB per user), genetic modifier lookup tables (~48 KB), 24-hour circadian modifier tables, personal baseline histories (Welford accumulators per biomarker type), and real-time synchronized frame buffers;
- **Persistent Storage:** Non-volatile storage (flash memory) for persisting per-user calibration profiles (δ_base, κ_genetic, δ_circ corrections) across device power cycles and application sessions, enabling continuous self-calibration refinement over weeks and months;
- **Hardware Communication Interfaces:** Bluetooth Low Energy (BLE) 5.0+ for real-time CGM data ingestion (≤5-minute polling intervals), wearable heart rate sensor streaming, and sleep tracker synchronization; Near-Field Communication (NFC) for one-time genetic test result import;
- **Secure Enclave / Trusted Execution Environment (TEE):** Hardware-isolated secure processing region for genetic data decryption and SNP modifier computation, ensuring that raw genetic sequences are never exposed to the general-purpose operating system kernel or user-space applications;
- **Network Interface:** Wi-Fi or cellular modem for transmitting only the privacy-protected 64-dimensional embedding vector and differential-privacy-noised aggregate statistics to the remote server. The network interface enforces a **cryptographic privacy boundary** — outgoing data is validated against a schema whitelist that physically prevents raw biomarker values, genetic data, or individually identifiable health measurements from being included in any network packet.

**(b) Server (Cloud):** An HL7 FHIR R4-compliant server that receives only privacy-protected outputs from edge devices. The server provides dietary recommendation generation, population-level analytics, and FHIR-compatible electronic health record (EHR) integration. The server cannot reconstruct raw biomarker values, individual genotypes, or specific health measurements from the received embeddings due to the irreversibility of the differential privacy noise injection and the dimensionality reduction from full biomarker state to 64-dimensional embedding.

The edge device receives biomarker data through a set of modular **BiomarkerSource Adapters**, each implementing a standardized interface:

- **CGM Adapter:** Ingests continuous glucose monitoring data (sampling interval: ~5 minutes, temporal behavior: CONTINUOUS, physiological lag: 60 minutes including digestion, absorption, and interstitial sensor diffusion delay);
- **Activity Adapter:** Ingests heart rate (physiological lag: 30 seconds), heart rate variability (HRV, lag: 5 minutes), step count (lag: 20 minutes), and exercise data (lag: 4 hours for delayed metabolic effects) from wearable sensors;
- **Sleep Adapter:** Ingests sleep stage and duration summaries (sampling interval: once per day, temporal behavior: PERIODIC, physiological lag: 8 hours reflecting full prior-night sleep observation);
- **Genetic Adapter:** Ingests SNP genotype data from genetic testing services (sampling interval: one-time, temporal behavior: STATIC, physiological lag: 0 seconds);
- **Location Adapter:** Ingests location and environmental context data (physiological lag: 30 minutes for environmental exposure effects).

Each adapter declares its **SamplingCharacteristics**, a frozen data structure comprising:
- `typical_interval`: expected time between successive readings;
- `min_interval`: minimum physically possible interval;
- `max_gap_before_stale`: duration after which data is considered stale;
- `physiological_lag`: the inherent cause-effect delay in seconds;
- `temporal_behavior`: one of CONTINUOUS, EVENT, PERIODIC, or STATIC;
- `circadian_sensitivity`: a value in [0.0, 1.0] indicating susceptibility to circadian modulation;
- `noise_floor`: inherent measurement noise level.

This self-describing adapter architecture enables the synchronization engine to handle new biomarker sources without modification.

### 2. Unified Data Model: BiomarkerReading

All biomarker data is normalized into a unified **BiomarkerReading** data structure comprising:

| Field | Type | Description |
|---|---|---|
| source_id | string | Data source identifier (e.g., "dexcom_g7") |
| user_id | string | Pseudonymized user identifier |
| biomarker_type | BiomarkerType enum | One of 17 supported types |
| timestamp | datetime | Measurement timestamp (UTC) |
| value | float | Measured value |
| unit | string | Unit of measurement (e.g., "mg/dL", "bpm") |
| confidence | float | Measurement confidence [0.0, 1.0] |
| metadata | dictionary | FHIR-compatible metadata |
| raw_hash | string | SHA-256 integrity hash |

This structure enables heterogeneous data from CGMs, wearables, and genetic tests to be processed through a unified pipeline.

### 3. Stage 0: Dynamic Consent Filtering (FIG. 3)

The first processing stage enforces granular user consent at the algorithm level, not merely at the API access control level. A **Biomarker-Consent Mapping** table defines which consent scopes are required for each biomarker type:

| BiomarkerType | Required ConsentScope |
|---|---|
| GLUCOSE | GLUCOSE_DATA |
| HEART_RATE, HRV | HEART_RATE_DATA |
| STEPS, EXERCISE | ACTIVITY_DATA |
| SLEEP_STAGE, SLEEP_DURATION | SLEEP_DATA |
| GENOTYPE | GENETIC_DATA |

**Key behaviors:**

(i) If GENETIC_DATA consent is not granted, all `genetic_modifiers` are reset to population defaults (γ = 1.0), and the system proceeds with non-personalized lag computation.

(ii) Consent revocation takes effect within the same request cycle (strong consistency, not eventual consistency).

(iii) An audit trail records all filtered biomarker types per request.

This design ensures GDPR Article 7 and HIPAA §164.508 compliance at the algorithmic level.

### 4. Stage 1: Temporal Synchronization — The Core Invention (FIG. 2, FIG. 3)

#### 4.1 The Dynamic Physiological Lag Model

The central innovation of the present invention is a **Dynamic Physiological Lag Model** that computes a personalized, time-varying lag duration for each biomarker signal.

Given a biomarker reading of type b, recorded at timestamp t_event, with user genetic profile g and current time-of-day c, the lag-compensated synchronization timestamp is:

**t_sync = t_event + Δt_base(b) × γ_genetic(g) × φ_circadian(c)**

##### 4.1.1 Δt_base(b) — Intrinsic Physiological Lag

Each biomarker type has a biologically determined base lag representing the inherent delay between cause and effect:

| Biomarker Type | Base Lag (seconds) | Biological Basis |
|---|---|---|
| GLUCOSE | 3,600 (60 min) | Digestion, absorption, interstitial equilibration, sensor diffusion delay |
| HEART_RATE | 30 (0.5 min) | Autonomic nervous system response (fast neural pathway) |
| HRV | 300 (5 min) | Parasympathetic modulation time constant |
| STEPS | 1,200 (20 min) | Accelerometer aggregation and processing latency |
| SLEEP_STAGE | 28,800 (8 hr) | Full sleep cycle observation (reflects prior night's complete sleep) |
| EXERCISE | 14,400 (4 hr) | Delayed metabolic effects of exercise (EPOC) |
| BODY_TEMPERATURE | 1,800 (30 min) | Thermoregulatory response latency |
| GENOTYPE | 0 | Static measurement, no temporal lag |

These values are stored as default parameters in the `PhysiologicalLagModel` class and can be overridden per user through the self-calibration mechanism described in Section 7.

##### 4.1.2 γ_genetic(g) — Genetic Metabolic Rate Modifier

The genetic modifier γ is derived from the user's SNP (Single Nucleotide Polymorphism) profile. For each biomarker type b, the system identifies all SNPs whose metabolic modifiers affect that biomarker. The genetic factor is computed as the geometric mean of the inverse of each modifier:

**γ_genetic = exp( (1/k) × Σᵢ ln(1/mᵢ) )**

where mᵢ is the metabolic modifier coefficient for the i-th relevant SNP, and k is the count of relevant SNPs. The result is clamped to [0.5, 2.0] to prevent physiologically implausible values.

**Example:** For a user with TCF7L2 rs7903146 T/T genotype:
- insulin_response_modifier = 0.8 (20% weaker insulin response)
- γ_genetic = 1/0.8 = 1.25 (25% longer glucose clearance lag)

For a user with CYP1A2 rs762551 A/C genotype:
- caffeine_metabolism_rate = 0.5 (50% slower caffeine metabolism)
- γ_genetic for caffeine-related biomarkers = 1/0.5 = 2.0

The system supports 8 core nutrigenomics SNPs yielding 22 modifier keys, of which 17 directly map to nutrient target adjustments:

| SNP (rsID) | Gene | Metabolic Effect | Nutrient Adjustment |
|---|---|---|---|
| rs1801133 | MTHFR | Folate metabolism -50% | Folate ×1.5, B12 ×1.3 |
| rs9939609 | FTO | Obesity susceptibility | Calorie sensitivity ×1.2 |
| rs429358 | APOE | Lipid metabolism variant | Saturated fat sensitivity ×1.5 |
| rs7903146 | TCF7L2 | Insulin response weakened | Carbohydrate sensitivity ×1.3 |
| rs4988235 | LCT | Lactose intolerance | Lactose tolerance 0, Alt calcium ×1.5 |
| rs762551 | CYP1A2 | Slow caffeine metabolism | Caffeine metabolism ×0.5, Daily max 200mg |
| rs1544410 | VDR | Vitamin D receptor variant | Vitamin D ×1.4, Calcium absorption ×0.85 |
| rs4341 | ACE | Exercise response type | Strength response ×1.2, Endurance ×0.9 |

##### 4.1.3 φ_circadian(c) — Circadian Rhythm Modifier

Metabolic efficiency varies systematically with time of day. The circadian modifier is determined by a 24-hour lookup table with sub-hour linear interpolation:

| Hour | φ_circadian | Physiological Basis |
|---|---|---|
| 00:00 | 1.15 | Late night: minimal metabolic activity |
| 01:00 | 1.18 | Deep night: slow metabolism |
| 02:00 | 1.20 | Circadian nadir: lowest metabolic rate |
| 03:00 | 1.18 | Late nadir: beginning recovery |
| 04:00 | 1.10 | Pre-dawn: metabolic transition |
| 05:00 | 1.00 | Dawn: cortisol surge begins |
| 06:00 | 0.90 | Dawn phenomenon: rising insulin sensitivity |
| 07:00 | 0.85 | Morning: high insulin sensitivity |
| 08:00 | 0.82 | Peak morning: highest insulin sensitivity |
| 09:00 | 0.85 | Mid-morning: sustained high efficiency |
| 10:00 | 0.88 | Late morning: gradual decline |
| 11:00 | 0.90 | Pre-noon |
| 12:00 | 0.92 | Noon |
| 13:00 | 0.95 | Early afternoon |
| 14:00 | 0.98 | Mid-afternoon |
| 15:00 | 1.00 | Afternoon: baseline reference |
| 16:00 | 1.02 | Late afternoon: efficiency declining |
| 17:00 | 1.05 | Pre-evening |
| 18:00 | 1.03 | Early evening: moderate decline |
| 19:00 | 1.00 | Evening: brief stabilization |
| 20:00 | 1.05 | Late evening: declining efficiency |
| 21:00 | 1.08 | Pre-sleep transition |
| 22:00 | 1.10 | Night: metabolism slowing |
| 23:00 | 1.12 | Late night: approaching nadir |

Sub-hour interpolation is computed as:

**φ(t) = φ_current + (φ_next − φ_current) × (minute / 60)**

This ensures smooth, continuous transitions without discontinuities.

##### 4.1.4 Practical Example

**Scenario:** TCF7L2 T/T carrier eats a meal at 8:00 AM:
- Δt_base(GLUCOSE) = 60 minutes
- γ_genetic = 1.25 (from TCF7L2 T/T)
- φ_circadian(08:00) = 0.82 (morning peak)
- **Computed lag = 60 × 1.25 × 0.82 = 61.5 minutes**

**Same user eats at 10:00 PM:**
- Δt_base(GLUCOSE) = 60 minutes
- γ_genetic = 1.25
- φ_circadian(22:00) = 1.10 (evening decline)
- **Computed lag = 60 × 1.25 × 1.10 = 82.5 minutes**

→ For the same individual consuming the same meal, the glucose response lag differs by 34% depending on time of day. This is the critical temporal information that no prior art system captures.

#### 4.2 Multi-Resolution Temporal Synchronization

The **TemporalSynchronizer** class aligns all lag-compensated signals onto a unified temporal grid at three resolution levels:

| Resolution | Window Size | Use Case |
|---|---|---|
| FINE | 5 minutes | Real-time dashboard, CGM monitoring |
| MEDIUM | 1 hour | Hourly nutrition analysis |
| COARSE | 24 hours | Daily summary, trend reports |

For each time window [t, t+Δ], the synchronizer:

(i) Queries the `PhysiologicalLagModel` for the lag of each biomarker type b;

(ii) Computes the lag-compensated query window: [t − lag(b), t + Δ − lag(b)];

(iii) Collects raw readings within the compensated window;

(iv) If no readings are found, checks data staleness and either interpolates (via the CircadianInterpolator) or sets confidence to 0;

(v) Aggregates readings according to their `TemporalBehavior`:
   - **CONTINUOUS** (e.g., glucose, heart rate): Distance-weighted mean using Gaussian kernel weights: w_i = exp(−0.5 × (Δt_i/σ)²) × confidence_i
   - **EVENT** (e.g., meals, exercise): Sum of all events within the window
   - **PERIODIC** (e.g., sleep): Most recent value with decay
   - **STATIC** (e.g., genotype): Always current value, no decay

The output is a **SynchronizedFrame** containing all signals aligned to a single time snapshot, with per-signal confidence scores and overall frame completeness.

#### 4.3 Staleness Decay Function

Rather than a binary fresh/stale determination, the system implements continuous confidence decay:

**decay = exp(−0.693 × gap / half_life)**

where `gap` is the time since the last reading and `half_life` equals the typical sampling interval for that biomarker type. This provides a smooth, physiologically meaningful degradation of signal reliability.

### 5. Stage 2: Physiological Normalization (FIG. 9)

#### 5.1 Genetic Baseline Calculator

Rather than comparing biomarker values to population averages, the system computes **genotype-adjusted reference ranges**:

**μ_genetic(b) = μ_population(b) × (1 + Σ shift_pct_i / 100)**

**σ_genetic(b) = σ_population(b) × (1 − 0.05 × n_variants)** (minimum 60% of population σ)

The confidence in the genetic baseline is modeled as a sigmoid function of the number of relevant genetic variants:

**confidence = 1 / (1 + exp(−0.5 × (n − 4)))**

**Example:** For a TCF7L2 T/T carrier:
- Population glucose baseline: μ = 100 mg/dL, σ = 15 mg/dL
- Genetic adjustment: μ_genetic = 106 mg/dL, σ_genetic = 12 mg/dL
- A reading of 108 mg/dL:
  - Population Z-score: (108 − 100) / 15 = +0.53 → "slightly elevated"
  - **Genetic Z-score: (108 − 106) / 12 = +0.17 → "normal for this genotype"**

This distinction is clinically significant: the population-based Z-score would trigger an unnecessary alert, while the genotype-aware Z-score correctly identifies the reading as within normal range for this individual.

#### 5.2 Five-Step Normalization Pipeline

The **PhysiologicalNormalizer** applies five sequential transformations:

**(1) Circadian Correction:** Removes expected time-of-day variation using pre-computed circadian profiles for each biomarker type. adjusted = raw − circadian_offset(hour).

**(2) Personal Z-Score:** Computes Z-score using a priority cascade: personal learned baseline (if mature, ≥50 samples, preferred as the most faithful representation of individual physiology) → genetic baseline (if available with sufficient confidence >0.3) → population baseline (fallback).

**(3) Context-Dependent Scaling:** The same Z-score is interpreted differently based on metabolic context. For example, a moderately elevated glucose Z-score during postprandial_early state is scaled by 0.7 (expected and physiologically normal), while the same Z-score during sleeping is scaled by 1.2 (clinically concerning). Fasting glucose retains a neutral scaling factor of 1.0 as the reference baseline. Exercise-related heart rate readings are scaled by 0.4 to suppress expected exercise-induced elevation.

**(4) Genetic Modifier Weighting:** Applies average genetic modifiers relevant to the biomarker type as additional weighting.

**(5) Anomaly Score:** Computes an anomaly index in [0, 1]: anomaly = 1 − exp(−0.5 × z_genetic²).

#### 5.3 Personal Baseline Learning

The **PersonalBaseline** module implements dual-timescale Exponential Weighted Moving Average (EWMA) learning:

- **Short-term EWMA** (α = 0.1, ~20-point window): Captures recent trends
- **Long-term EWMA** (α = 0.01, ~200+ point window): Captures stable personal baseline

Variance is tracked using Welford's online algorithm. Hourly mean profiles are maintained for circadian pattern detection. The baseline is considered "mature" after 50 samples.

### 6. Stage 3: Circadian-Aware Interpolation

The **CircadianInterpolator** fills data gaps using a biologically-informed model rather than naive linear interpolation.

#### 6.1 Dual-Component Circadian Model

**c(t) = baseline × (1 + A_c × cos(2π(h − φ_c)/24) + A_u × cos(2πh/T_u))**

where:
- A_c = circadian amplitude (e.g., 0.08 for glucose, 0.15 for heart rate, 0.20 for HRV)
- φ_c = circadian phase peak hour + personal phase offset
- A_u = ultradian amplitude (e.g., 0.03)
- T_u = ultradian period (typically 90 minutes, corresponding to the Basic Rest-Activity Cycle)

Pre-defined rhythm models:

| Biomarker | A_c | φ_c (peak hour) | A_u | T_u |
|---|---|---|---|---|
| GLUCOSE | 0.08 | 07:00 | 0.03 | 90 min |
| HEART_RATE | 0.15 | 15:00 | 0.02 | 90 min |
| HRV | 0.20 | 03:00 (slow-wave sleep) | 0.05 | 90 min |

#### 6.2 Adaptive Blending with Measured Data

When neighboring measured values exist, the interpolator blends circadian predictions with neighbor-based estimates using a sigmoid ratio:

**r = 1 / (1 + exp(−(gap_hours − 2.0) / 0.6))**

- Short gaps (< 1 hour): Heavily weight measured neighbors (r ≈ 0)
- Long gaps (> 3 hours): Rely on circadian model (r ≈ 1)

**Final interpolation: value = (1 − r) × neighbor_estimate + r × circadian_prediction**

Confidence decays exponentially with gap duration: confidence = exp(−gap / max_gap).

#### 6.3 Personal Phase Learning

The system learns individual circadian phase offsets by binning historical measurements into hourly buckets, identifying peak times, and comparing against population-average peak times to compute a personal phase deviation.

### 7. Adaptive Self-Calibration Feedback Loop (FIG. 4)

#### 7.1 Overview

The static three-axis lag formula produces accurate initial estimates, but individual biological variation may cause systematic prediction errors. The **Adaptive Self-Calibration Feedback Loop** continuously refines per-user lag predictions by comparing predicted peak times against observed peak times in post-event biomarker data.

#### 7.2 Peak Detection Algorithm

The **PeakDetector** class identifies actual biomarker response peaks in time series data through a four-step process:

**(1) EMA Smoothing:** Raw readings are smoothed using Exponential Moving Average with α = 0.3 to remove sensor noise while preserving physiological signal features.

**(2) Local Maximum Identification:** Points where the smoothed value exceeds both the preceding and following values are identified as candidate peaks.

**(3) Prominence Filtering:** For each candidate peak, prominence is computed as: prominence = peak_value − max(left_trough, right_trough). Only peaks with prominence > 10% of the total signal range are retained.

**(4) Confidence Scoring:** The highest-prominence peak is selected, with confidence = min(1.0, prominence / signal_range).

#### 7.3 Three-Channel Error Back-Propagation

Given a prediction error ε = actual_peak_time − predicted_peak_time:

**(Channel 1) Base Lag Offset Update:**
δ_base(b)^(k+1) = (1 − α_base) × δ_base(b)^(k) + α_base × ε
Clamp: ±1,800 seconds (±30 minutes)

**(Channel 2) Circadian Phase Correction Update:**
δ_circ(h)^(k+1) = (1 − α_circ) × δ_circ(h)^(k) + α_circ × (ε / predicted_lag)
Clamp: ±0.3

**(Channel 3) Genetic Coefficient Correction Update:**
κ^(k+1) = (1 − α_genetic) × κ^(k) + α_genetic × (1 + ε_relative)
Clamp: [0.5, 1.5]

#### 7.4 Adaptive Learning Rate Schedule

Each channel uses a decaying learning rate:

**α(k) = α₀ / (1 + k / τ)**

| Channel | α₀ (initial rate) | τ (decay constant) | Rationale |
|---|---|---|---|
| Base lag | 0.3 | 20 | Fast initial adaptation |
| Circadian | 0.2 | 20 | Moderate adaptation |
| Genetic | 0.1 | 20 | Conservative (genotype is immutable, only coefficient interpretation changes) |

This schedule ensures rapid learning from early observations while achieving stable convergence as data accumulates.

#### 7.5 Convergence Determination

The system automatically determines calibration convergence using a weighted composite score:

**convergence_score = 0.6 × improvement + 0.4 × stability**

where:
- improvement = 1 − (MAE_recent / MAE_early), comparing Mean Absolute Error of the first half vs. second half of observation history
- stability = 1 / (1 + std/mean), measuring coefficient of variation of recent errors

Convergence is declared when: observation_count ≥ 10 AND convergence_score > 0.8.

### 8. Stage 4: Composite Metabolic State Estimation (FIG. 10)

#### 8.1 14-Phase Metabolic Classification

Unlike prior art systems that classify metabolic state along a single axis (e.g., "fasting vs. fed"), the present invention simultaneously identifies **14 individual metabolic phases** across four categories:

| Category | Phases | Detection Criteria |
|---|---|---|
| Dietary | POSTPRANDIAL_EARLY (0-2h), POSTPRANDIAL_LATE (2-4h), POST_ABSORPTIVE (4-12h), FASTING (≥12h) | Time since last meal event; POST_ABSORPTIVE occupies 4-12h window, FASTING triggers only after ≥12h |
| Exercise | PRE_EXERCISE*, DURING_EXERCISE, RECOVERY_IMMEDIATE (0-2h), RECOVERY_DELAYED (2-48h for high/extreme) | DURING_EXERCISE: heart rate > 100 bpm; RECOVERY: time since exercise end + intensity classification |
| Sleep | PRE_SLEEP, SLEEPING, POST_WAKING (0-1h) | Time of day + activity level (steps < 5 → sleeping) |
| Stress/Recovery | METABOLIC_STRESS, RECOVERY, CIRCADIAN_LOW* | HRV < 30ms → METABOLIC_STRESS (intensity = 1 − HRV/30), HRV > 60ms → RECOVERY (intensity = (HRV−60)/40) |

*Note: PRE_EXERCISE and CIRCADIAN_LOW are defined in the MetabolicPhase enumeration as extension points for future sensor integration (e.g., pre-exercise warmup detection via accelerometer patterns, circadian low via per-user melatonin onset modeling). These phases are architecturally supported but not actively detected in the current embodiment.

Multiple phases can be active simultaneously. The critical insight is that **"fasting + sleeping" produces fundamentally different nutrient demands than "fasting + post-exercise recovery":**

| Composite State | Carbohydrate Priority | Protein Priority | Hydration Priority |
|---|---|---|---|
| Fasting + Sleeping | 0.8× (unnecessary) | 1.0× | 0.7× (prevent nocturia) |
| Fasting + Post-Exercise Recovery | 1.5× (glycogen replenishment) | 1.4× (muscle repair) | 1.5× (rehydration) |
| Postprandial Early + Stress | 0.6× (already fed) | 0.8× | 1.2× |

#### 8.2 HRV-Based Sleep Quality Estimation

The system estimates sleep quality using a two-signal weighted ensemble:

**sleep_quality = 0.6 × HRV_contribution + 0.4 × Duration_contribution**

**HRV contribution** is computed using a four-tier piecewise function reflecting clinical HRV norms:
- HRV ≥ 70ms (good autonomic recovery): hrv_quality = min(1.0, 0.8 + (HRV − 70) / 150)
- HRV ∈ [50, 70) (average recovery): hrv_quality = 0.5 + (HRV − 50) / 66.7
- HRV ∈ [30, 50) (below-average recovery): hrv_quality = 0.25 + (HRV − 30) / 80
- HRV < 30ms (poor autonomic recovery): hrv_quality = max(0.1, HRV / 120)

This piecewise formulation, derived from clinical HRV reference ranges, provides more physiologically accurate mapping than a simple linear function because autonomic recovery quality is non-linearly related to absolute HRV values.

**Duration contribution** uses a five-tier piecewise function reflecting sleep medicine evidence on optimal sleep duration:
- < 4h (severe deficit): dur_quality = 0.15
- [4h, 6h) (moderate deficit): dur_quality = 0.15 + (duration − 4) × 0.175
- [6h, 7h) (mild deficit): dur_quality = 0.5 + (duration − 6) × 0.3
- [7h, 9h] (optimal range): dur_quality = 0.8 + min(0.2, (duration − 7) × 0.1)
- > 9h (oversleeping penalty): dur_quality = max(0.6, 1.0 − (duration − 9) × 0.1)

If both a recorded sleep quality score and computed duration quality are available, they are averaged: duration_contribution = (dur_quality + recorded_quality) / 2.0.

#### 8.3 Sleep Debt Impact on Insulin Sensitivity

When sleep quality falls below 0.7, an insulin sensitivity penalty is applied:

**penalty = 0.12 × (1 − sleep_quality / 0.7)**

Maximum penalty: −0.12 (at sleep_quality = 0). This quantifies the clinically established relationship between sleep deprivation and impaired glucose metabolism.

### 9. Stage 4.5: Context-Aware Re-Normalization

After metabolic state estimation in Stage 4, the normalization computed in Stage 2 may be suboptimal because the metabolic context was unknown at that time. Stage 4.5 performs **selective re-normalization**:

(i) Obtain confirmed metabolic context from Stage 4: metabolic_state.to_context_string()

(ii) For each biomarker type, compare old context factor ("unknown") with new context factor (confirmed state)

(iii) Re-normalize only signals where |old_factor − new_factor| > 0.01 to avoid unnecessary recomputation

(iv) Set update_baseline = False to prevent double-counting of adaptive baseline updates

### 10. Stage 5: Nutrient Demand Calculation (FIG. 6)

#### 10.1 Eight-Step Calculation Algorithm

**(Step 1) Base Daily Targets:** Establish 14 nutrient targets based on Recommended Dietary Allowances (RDA): 6 macronutrients (kcal, carbs_g, protein_g, fat_g, fiber_g, water_ml) and 8 micronutrients (folate_mcg, b12_mcg, vitamin_d_iu, magnesium_mg, calcium_mg, sodium_mg, caffeine_mg, vitamin_b6_mg).

**(Step 2) Metabolic State Modifiers:** Apply multiplicative nutrient priority shifts from all active metabolic phases (e.g., DURING_EXERCISE → carbs ×1.8, water ×2.0).

**(Step 3) Genetic Modifiers:** Apply SNP-based nutrient efficiency coefficients. 17 genetic modifier keys map to specific nutrient targets (e.g., MTHFR CT → folate ×1.5, B12 ×1.3).

**(Step 4) Biomarker-Reactive Adjustments:** Apply real-time adjustments based on normalized biomarker Z-scores:
- Glucose Z > 1.5 → reduce carbohydrate target up to −25%
- Glucose Z < −1.0 → increase carbohydrate target up to +20%
- HRV Z < −1.0 (stress) → increase magnesium and vitamin B6 up to +15%
- Heart Rate Z > 1.0 (suspected dehydration) → increase water target up to +30%
- All adjustments are proportionally scaled and capped at stated maximums.

**(Step 5) Consumption Deduction:** Subtract already-consumed amounts: remaining = target − consumed_today.

**(Step 6) Hierarchical Conflict Resolution:** Resolve conflicts between genetic optimization and medical safety constraints (detailed in Section 10.2).

**(Step 7) Time Bucket Distribution:** Distribute remaining nutrient budget across temporal windows based on current metabolic state. Recovery states generate immediate "Recovery Window" buckets with elevated carbohydrate (40%) and protein (35%) allocations. Standard states use Morning/Afternoon/Evening distribution. Pre-sleep states reduce evening carbohydrate allocation to 10%.

**(Step 8) Output Generation:** Produce a complete NutrientBudget containing targets, time buckets, modification audit trail, conflict resolutions, and overall confidence score.

#### 10.2 Hierarchical Conflict Resolution Layer (FIG. 6)

When genetically-optimized nutrient targets conflict with medical safety thresholds, the system applies a strict priority hierarchy:

| Priority (highest) | Layer | Description | Overridable? |
|---|---|---|---|
| 5 | Medical Critical | Life-threatening — CKD, severe allergies | Never |
| 4 | Medical Warning | Clinically significant — hypertension, diabetes | Never |
| 3 | Genetic Optimization | SNP-based nutrient efficiency | By medical constraints |
| 2 | Biomarker Reactive | Real-time Z-score adjustments | Yes |
| 1 | Metabolic State | Phase-specific modifiers | Yes |
| 0 | Base RDA | Population-level defaults | Yes |

**Conflict Resolution Algorithm:**

(i) Track which nutrients have been modified by genetic optimization.

(ii) Sort medical constraints by priority (Critical before Warning).

(iii) For each constraint, check if current target exceeds the medical limit.

(iv) If exceeded: clamp target to medical limit, classify the conflict, record the winner (medical) and loser (genetic/metabolic), compute safety margin, and generate a human-readable rationale.

(v) Generate a **ConflictResolution** audit record for every resolved conflict:

```
ConflictResolution {
    nutrient: string,              // e.g., "protein_g"
    conflict_type: string,         // e.g., "genetic_vs_medical"
    genetic_recommended: float,    // e.g., 126.0
    medical_limit: float,          // e.g., 56.0
    resolved_value: float,         // e.g., 56.0
    winner: string,                // "medical_critical"
    loser: string,                 // "genetic"
    safety_margin: float,          // e.g., 0.0
    constraint_reason: string,     // "CKD stage 3"
    resolution_rationale: string   // Human-readable explanation
}
```

**Example Conflict Scenario:**
- User genotype: TCF7L2 T/T (carbohydrate sensitivity ×1.3) + ACE D/D (strength response ×1.2, recommending protein ×1.5)
- Medical condition: Chronic Kidney Disease (CKD) Stage 3
- Genetic recommendation: protein = 84g × 1.5 = 126g
- Medical constraint: protein ≤ 56g (CKD critical limit)
- **Resolution:** Target clamped to 56g; winner = "medical_critical"; rationale = "Genetic optimization recommends 126.0g protein, but CKD stage 3 requires protein ≤ 56g. Medical safety constraint takes absolute precedence."

### 11. Stage 6: Dynamic Differential Privacy (FIG. 7)

#### 11.1 Four-Tier Sensitivity Classification

The system classifies each data type into one of four sensitivity tiers, each receiving a different privacy budget allocation:

| Tier | ε (epsilon) | Noise Intensity | Data Types |
|---|---|---|---|
| CRITICAL | 0.1 | Maximum protection | Genetic data, rare conditions |
| HIGH | 0.3 | Strong protection | Glucose, blood tests, medications |
| MEDIUM | 0.5 | Moderate protection | Heart rate, HRV, sleep |
| LOW | 0.8 | Light protection | Steps, exercise, activity calories |

#### 11.2 Adaptive Budget Management

The **DynamicEpsilonAllocator** adapts epsilon allocation based on cumulative budget consumption:

- Budget usage < 70%: Full epsilon (α = 1.0)
- Budget usage 70-89%: Reduced epsilon (α = 0.75)
- Budget usage ≥ 90%: Minimum epsilon (α = 0.5)

Total per-user privacy budget: ε_total = 1.0, δ = 10⁻⁵, with 24-hour reset cycle.

#### 11.3 Noise Injection Mechanisms

For each nutrient target v_n with sensitivity tier τ(n):

**ṽ_n = v_n + Lap(Δ_n / (ε_τ(n) × α(B)))**

where Lap(·) denotes a sample from the Laplace distribution, Δ_n is the sensitivity of nutrient n, and α(B) is the adaptive budget coefficient.

The system also supports Gaussian mechanism for (ε,δ)-DP with:

**σ = (sensitivity × √(2 ln(1.25/δ))) / ε**

#### 11.4 Privacy Exposure Index (PEI)

The system tracks cumulative privacy exposure:

**PEI = Σ ε_consumed / B_total**

| PEI Range | Risk Level | System Response |
|---|---|---|
| 0.0-0.39 | Low | Normal operation |
| 0.4-0.69 | Moderate | Enhanced monitoring |
| 0.7-0.89 | High | ε reduced by 25% |
| 0.9-1.0 | Critical | ε reduced by 50%, preserve remaining budget |

### 12. Validation and Experimental Results (FIG. 8)

#### 12.1 Synthetic Data Validation

The system was validated using **Synthea**, an open-source synthetic patient generator producing HL7 FHIR R4-compliant clinical data. Five synthetic patients (aged 25-45, Massachusetts) generated 234 biomarker readings mapped through 25+ LOINC codes.

#### 12.2 Real-World Data Validation

The **OhioT1DM** dataset (Type 1 Diabetes patients with continuous CGM + meal + insulin records) was used to directly validate the physiological lag model. The validation pipeline measures Pearson correlation improvement between raw and lag-compensated meal-to-glucose temporal alignment.

#### 12.3 Quantitative Results

| Metric | Before Lag Compensation | After Lag Compensation | Improvement |
|---|---|---|---|
| Meal-Glucose Pearson Correlation | ~0.15 (weak) | ~0.78 (strong) | +420% |
| Peak Timing Error (MAE) | ~45 minutes | ~8 minutes | −82% |
| Causal Event Detection Rate | Not possible | 14/15 meal matches | 93% |

These results demonstrate that the dynamic physiological lag model dramatically improves the ability to identify causal relationships between nutrient intake and biomarker responses, a capability absent in all prior art systems.

### 13. Technical Character of the Invention — Subject Matter Eligibility Analysis

The following analysis is provided to demonstrate that the present invention constitutes patent-eligible subject matter under 35 U.S.C. § 101, consistent with the Alice Corp. v. CLS Bank (2014) two-step framework and subsequent Federal Circuit guidance.

#### 13.1 Alice Step 1: The Claims Are Not Directed to an Abstract Idea

The claims of the present invention are not directed to a mathematical formula, a mental process, or a method of organizing human activity. Rather, they are directed to **a specific improvement in the technological process of synchronizing heterogeneous sensor data streams** — a concrete problem that exists only in the context of computer-mediated biomarker data processing.

Under *Enfish, LLC v. Microsoft Corp.*, 822 F.3d 1327 (Fed. Cir. 2016), claims directed to improvements in computer functionality itself — rather than merely using a computer as a tool — are patent-eligible at Step 1. The present invention improves the functioning of the computing system in at least four specific ways:

**(a) Improved Data Processing Accuracy:** The lag-compensated temporal synchronization transforms unreliable cross-signal correlation (r ≈ 0.15) into actionable correlation (r ≈ 0.78). This is an improvement to the computer's ability to process data correctly, analogous to the improved database structure in *Enfish*.

**(b) Improved Computational Adaptability:** The three-channel self-calibration feedback loop enables the computing system to autonomously improve its own prediction accuracy over time (MAE 45 min → 8 min) without human reprogramming. This constitutes an improvement to how the computer functions, not merely a new use of conventional computing.

**(c) Reduced Data Transmission Requirements:** The edge-cloud architecture with privacy boundary reduces network data transmission by processing all seven pipeline stages on-device and transmitting only a fixed-size 64-dimensional embedding. This is a concrete architectural improvement that reduces bandwidth, latency, and privacy risk.

**(d) Specific Data Structure Improvements:** The BiomarkerReading data structure with self-describing SamplingCharacteristics enables the synchronization engine to handle new biomarker sources without software modification — an improvement to the extensibility of the computing system analogous to the self-referential table in *Enfish*.

#### 13.2 Alice Step 2 (If Reached): The Claims Recite Significantly More

Even if any aspect of the claims were deemed directed to an abstract idea at Step 1, the claims recite an "inventive concept" constituting "significantly more" under Step 2:

**(a) Unconventional Ordered Combination (BASCOM Analysis):**

The seven-stage pipeline represents an unconventional ordered combination of processing steps. Under *BASCOM Global Internet Services v. AT&T Mobility*, 827 F.3d 1341 (Fed. Cir. 2016), even conventional components can constitute an inventive concept when arranged in a non-conventional manner. The specific sequence — consent filtering → lag-compensated synchronization → genotype-aware normalization → circadian interpolation → composite metabolic state estimation → context-aware re-normalization → conflict resolution with medical safety enforcement → differential privacy — is not a routine or conventional arrangement. No prior art system performs these steps, let alone in this specific order.

**(b) Specific Machine Transformation — The Edge Device as a Special-Purpose Machine:**

The claims require a specific hardware configuration: CGM sensors physically attached to the user's body via subcutaneous filament, wearable PPG/ECG cardiac sensors, an ARM-based edge computing processor with secure enclave for genetic data, persistent flash storage for calibration profiles, and a network interface with hardware-enforced privacy boundary. The edge device, as programmed with the seven-stage pipeline and operatively coupled to these sensors, constitutes a **special-purpose biomarker temporal synchronization machine** under *In re Alappat* — a new machine that did not exist in the prior art. The claimed method cannot be performed mentally, on paper, or through generic computer implementation — it requires real-time fusion of 5+ concurrent streaming sensor data channels with different physical measurement modalities (electrochemical, optical, mechanical, molecular) within a 500ms processing budget.

**(c) The Claims Do Not Preempt All Uses of the Underlying Concepts:**

The claims are narrow and specific. They do not preempt all uses of circadian rhythm modeling, genetic modifier computation, or differential privacy. They claim a *specific combination* of these techniques in a *specific ordered pipeline* executed on *specific hardware* (edge devices with biomarker sensors) for a *specific purpose* (temporal synchronization of heterogeneous biomarker signals for nutrient budget computation). Other systems could use alternative lag models, different normalization approaches, or different privacy mechanisms without infringing.

**(d) Non-Conventional Sensor Integration:**

The adapter architecture with self-describing SamplingCharacteristics (declaring typical_interval, physiological_lag, temporal_behavior, circadian_sensitivity, and noise_floor per sensor type) is a specific technical mechanism for integrating physically heterogeneous sensors. This goes beyond mere data collection — it provides a structured framework that enables the synchronization engine to automatically adapt its processing strategy based on declared sensor properties, without requiring per-sensor-type code modifications.

#### 13.3 Comparison with Relevant Case Law

| Case | Holding | Present Invention Alignment |
|---|---|---|
| *Enfish v. Microsoft* (2016) | Self-referential database table improved computer functionality → patent-eligible | BiomarkerReading with SamplingCharacteristics improves how computing system processes heterogeneous sensor data |
| *McRO v. Bandai Namco* (2016) | Lip-sync rules improved technological process → patent-eligible | Physiological lag rules improve temporal synchronization process |
| *BASCOM v. AT&T* (2016) | Unconventional ordered combination → inventive concept | Seven-stage pipeline in physiologically-constrained order |
| *DDR Holdings v. Hotels.com* (2014) | Solution rooted in computer technology → Step 2 satisfied | Edge-cloud privacy architecture is inherently a computer-technological solution |
| *Athena Diagnostics v. Mayo* (2019) | Diagnostic method using known correlations → not eligible | Distinguished: present invention does not diagnose disease; it computes nutrient budgets through a specific data processing pipeline |
| *Alice v. CLS Bank* (2014) | Abstract idea implemented on generic computer → not eligible | Distinguished: present invention requires specific sensor hardware, edge computing, and unconventional pipeline arrangement |

#### 13.4 Examiner Response Strategy

If an Office Action raises a § 101 rejection, the following arguments should be presented:

**(i) Primary Argument — Not Directed to an Abstract Idea (Step 1):**
The claims are directed to a specific improvement in the technological process of processing multi-sensor biomedical data. The three-axis lag model is not a mathematical formula applied in the abstract; it is a technical mechanism for aligning physically heterogeneous sensor data streams that have different sampling rates (5 min to 1/lifetime), different temporal behaviors (CONTINUOUS, EVENT, PERIODIC, STATIC), and different causal delays (0 seconds to 8 hours). This problem exists only in the context of computer-mediated sensor data processing and has no analogue in manual or mental processes.

**(ii) Secondary Argument — Significantly More (Step 2):**
Point to the unconventional seven-stage pipeline, the self-calibrating feedback loop, the specific hardware requirements (CGM, wearables, edge processor), the concrete quantified improvement (420% correlation improvement, 82% error reduction), and the specific data structures (BiomarkerReading, SamplingCharacteristics, SynchronizedFrame, NutrientBudget, ConflictResolution).

**(iii) Tertiary Argument — Not a Diagnostic Method:**
The system does not diagnose any disease or medical condition. It computes nutrient budgets — food recommendations — through a data processing pipeline. The output is a NutrientBudget (a data structure), not a diagnosis, prognosis, or treatment plan. The system is a wellness/nutrition tool, not a medical device making diagnostic determinations.

---
## CLAIMS

What is claimed is:

### Independent Claim 1 — Dynamic Physiological Lag Model

**1.** A computer-implemented method for temporally synchronizing heterogeneous biomarker data streams for personalized nutrition recommendation, the method executed by a processor operatively coupled to at least one biomarker sensor device, the method producing a measurable improvement in cross-signal temporal alignment accuracy over prior art timestamp-based sorting, the method comprising:

(a) receiving, by the processor via hardware communication interfaces, a plurality of biomarker readings from at least two physically distinct biomarker sensor devices selected from the group consisting of: a continuous glucose monitor (CGM) attached to the user's body and producing interstitial glucose readings at approximately 5-minute intervals, a wearable heart rate sensor producing cardiac rhythm data, a sleep tracking device, and a genetic testing service providing SNP genotype data stored in a non-transitory computer-readable medium;

(b) for each biomarker reading, computing a personalized physiological lag duration that accounts for the physical signal propagation characteristics of the originating sensor device, according to:

**t_sync = t_event + Δt_base(b) × γ_genetic(g) × φ_circadian(c)**

wherein:
  - t_event is the timestamp of the biomarker reading;
  - Δt_base(b) is a biomarker-type-specific intrinsic physiological lag representing the inherent biological cause-effect delay for biomarker type b, declared by each sensor adapter (e.g., 3,600 seconds for glucose, 30 seconds for heart rate, 300 seconds for HRV);
  - γ_genetic(g) is a genetic metabolic rate modifier derived from the user's Single Nucleotide Polymorphism (SNP) profile, computed as a geometric mean of inverse metabolic modifier coefficients for relevant SNPs, clamped to a range of [0.5, 2.0];
  - φ_circadian(c) is a circadian rhythm modifier representing time-of-day metabolic efficiency, determined by the hour of t_event, ranging from a morning peak efficiency value to a late-night nadir value, with sub-hour linear interpolation;

(c) aligning the plurality of biomarker readings onto a unified multi-resolution temporal grid using the computed lag-compensated synchronization timestamps, wherein the multi-resolution temporal grid comprises at least two of: a fine resolution of approximately 5 minutes, a medium resolution of approximately 1 hour, and a coarse resolution of approximately 24 hours;

(d) for each time window of the temporal grid, aggregating aligned biomarker readings according to their temporal behavior classification, wherein continuous signals are aggregated using distance-weighted averaging with Gaussian kernel weights, event signals are aggregated by summation, periodic signals retain the most recent value with exponential decay, and static signals retain their current value without decay; and

(e) outputting a synchronized frame comprising all biomarker signals aligned to a common time reference with per-signal confidence scores, thereby transforming computationally unreliable cross-signal data (Pearson correlation r ≈ 0.15 under timestamp-based sorting) into computationally actionable temporally coherent data (Pearson correlation r ≈ 0.78 under the claimed lag-compensated synchronization), said improvement constituting a concrete, measurable enhancement to the data processing capability of the computing system.

---

### Independent Claim 2 — Adaptive Self-Calibration Feedback Loop

**2.** A computer-implemented method for adaptive calibration of a physiological lag prediction model, the method executed by an edge computing processor operatively coupled to at least one biomarker sensor device and a non-transitory computer-readable storage medium storing a persistent per-user calibration profile, the method producing a measurable improvement in temporal prediction accuracy over successive iterations, the method comprising:

(a) maintaining, in the non-transitory computer-readable storage medium, for each user, a personal calibration profile comprising three independent correction parameters: a per-biomarker base lag offset (δ_base), a multiplicative genetic coefficient correction (κ_genetic), and a per-hour circadian phase correction (δ_circ);

(b) predicting, using the physiological lag model with applied calibration corrections, a peak response time for a biomarker signal following a triggering event, wherein the calibrated lag is computed as:

**t_sync_cal = t_event + (Δt_base(b) + δ_base(b)) × (γ_genetic(g) × κ_genetic) × (φ_circadian(c) + δ_circ(h))**

(c) collecting post-event biomarker readings over a predetermined observation window;

(d) detecting an actual peak response time in the collected biomarker readings by:
  - applying Exponential Moving Average smoothing with a smoothing factor to remove sensor noise;
  - identifying local maxima where the smoothed value exceeds both adjacent values;
  - computing prominence for each candidate peak as the difference between the peak value and the maximum of adjacent troughs;
  - filtering candidates by a minimum prominence threshold proportional to the signal range; and
  - selecting the highest-prominence peak as the detected actual peak;

(e) computing a prediction error ε as the temporal difference between the detected actual peak time and the predicted peak time;

(f) back-propagating the prediction error through three independent correction channels:
  - updating the base lag offset: δ_base(b) ← (1 − α_base) × δ_base(b) + α_base × ε, clamped to ±1,800 seconds;
  - updating the circadian phase correction: δ_circ(h) ← (1 − α_circ) × δ_circ(h) + α_circ × (ε / predicted_lag), clamped to ±0.3;
  - updating the genetic coefficient correction: κ_genetic ← (1 − α_genetic) × κ_genetic + α_genetic × (1 + ε_relative), clamped to [0.5, 1.5];
  - wherein each correction channel uses an adaptive learning rate that decays according to α(k) = α₀ / (1 + k / τ), where k is the observation count and τ is a decay time constant; and

(g) applying the updated correction parameters to subsequent lag predictions by writing the updated parameters to the persistent calibration store, thereby transforming the computing system into a self-improving temporal alignment engine whose peak timing prediction accuracy autonomously improves from approximately 45-minute Mean Absolute Error to approximately 8-minute Mean Absolute Error without human intervention, said improvement being stored in and dependent upon the non-transitory computer-readable storage medium.

---

### Independent Claim 3 — Seven-Stage Processing Pipeline

**3.** A system for generating personalized real-time nutrient budget recommendations from heterogeneous biomarker data, the system comprising:

at least two physically distinct biomarker sensor devices operatively coupled to a user's body, the sensor devices producing biomarker data streams at different sampling rates and with different temporal behaviors;

an edge computing processor physically co-located with or proximate to the user, the edge computing processor having sufficient processing capacity to execute all seven pipeline stages in real time;

a non-transitory computer-readable storage medium storing pipeline instructions, user calibration profiles, and genetic modifier lookup tables;

a network interface for transmitting only privacy-protected outputs across a privacy boundary to a remote server, wherein raw biomarker values and genetic data do not cross the privacy boundary;

wherein the pipeline instructions, when executed by the edge computing processor, cause the processor to perform a seven-stage processing pipeline, each stage consuming the output of the preceding stage in a fixed physiologically-constrained order that cannot be reordered without producing biologically incorrect results, the pipeline comprising:

**(Stage 0) Consent Filtering:** enforcing granular user consent at the algorithm level by mapping each biomarker type to a required consent scope, physically removing non-consented biomarker readings from pipeline input, and resetting genetic modifiers to population defaults when genetic data consent is not granted;

**(Stage 1) Temporal Synchronization:** computing personalized lag-compensated synchronization timestamps for each biomarker reading using a dynamic physiological lag model that multiplies an intrinsic biomarker-specific lag by a genetic metabolic rate modifier and a circadian rhythm modifier, and aligning all readings onto a unified multi-resolution temporal grid;

**(Stage 2) Physiological Normalization:** computing genotype-adjusted Z-scores using a priority cascade that prefers a mature personal learned baseline (≥50 samples) over a genetic baseline (confidence > 0.3) over population baseline, applying circadian correction, context-dependent scaling, genetic modifier weighting, and anomaly scoring;

**(Stage 3) Circadian Interpolation:** filling data gaps in biomarker signals using a dual-component circadian rhythm model comprising a primary circadian oscillation with a 24-hour period and a secondary ultradian oscillation with approximately 90-minute period, blended with neighbor-based estimates using a sigmoid weighting function;

**(Stage 4) Metabolic State Estimation:** simultaneously classifying the user's current metabolic state across 14 enumerated phases in four categories comprising dietary phases (POSTPRANDIAL_EARLY, POSTPRANDIAL_LATE, POST_ABSORPTIVE, FASTING where FASTING triggers at ≥12 hours since last meal), exercise phases (including detection via heart rate > 100 bpm and intensity-based recovery classification), sleep phases, and stress/recovery phases (via HRV thresholds of 30ms and 60ms), and estimating insulin sensitivity incorporating HRV-based sleep quality with a quantified sleep debt penalty;

**(Stage 4.5) Context-Aware Re-Normalization:** selectively re-normalizing biomarker signals using the confirmed metabolic context from Stage 4, updating only signals where context factors have meaningfully changed;

**(Stage 5) Nutrient Demand Calculation:** computing personalized real-time nutrient budgets across at least 14 nutrient targets by sequentially applying base daily targets, metabolic state modifiers, genetic modifiers, biomarker-reactive adjustments, consumption deductions, hierarchical conflict resolution between genetic optimization and medical safety constraints, and temporal bucket distribution; and

**(Stage 6) Differential Privacy Noise Injection:** injecting calibrated noise from Laplace or Gaussian distributions with dynamically allocated privacy budgets based on a multi-tier data sensitivity classification.

---

### Independent Claim 4 — Hierarchical Conflict Resolution

**4.** A computer-implemented method for resolving conflicts between genetically-optimized nutrient targets and medical safety constraints in a personalized nutrition recommendation system, comprising:

(a) computing a set of genetically-optimized nutrient targets by applying SNP-derived metabolic modifiers to base dietary reference values, wherein the metabolic modifiers are derived from at least one of: MTHFR, FTO, APOE, TCF7L2, LCT, CYP1A2, VDR, and ACE gene variants;

(b) receiving a set of medical safety constraints, each constraint specifying a nutrient, a limit type (maximum or minimum), a limit value, and a priority level selected from at least two levels comprising Medical Critical and Medical Warning;

(c) for each nutrient, determining whether the genetically-optimized target exceeds a medical safety constraint;

(d) when a conflict is detected, resolving the conflict by unconditionally applying the medical safety constraint over the genetic optimization, regardless of the magnitude of the genetic recommendation;

(e) generating a conflict resolution audit record comprising: the conflicting nutrient, the conflict type, the genetically-recommended value, the medical limit value, the resolved value, the winning constraint source, the losing optimization source, a safety margin, the medical constraint reason, and a human-readable resolution rationale; and

(f) applying the resolved values to final nutrient targets while preserving the audit trail for regulatory compliance and clinical transparency.

---

### Independent Claim 5 — Dynamic Epsilon Differential Privacy

**5.** A computer-implemented method for protecting privacy of biomarker-derived nutrient recommendations, comprising:

(a) classifying each biomarker data type into one of a plurality of sensitivity tiers, wherein the sensitivity tiers comprise at least: a critical tier for genetic data with a first epsilon value, a high tier for glucose and blood test data with a second epsilon value greater than the first, a medium tier for heart rate and sleep data with a third epsilon value greater than the second, and a low tier for activity data with a fourth epsilon value greater than the third;

(b) maintaining a per-user privacy budget with a total epsilon allocation and a periodic reset cycle;

(c) for each nutrient recommendation derived from biomarker data, determining the sensitivity tier of the source biomarker data;

(d) computing an adaptive epsilon based on the tier-specific epsilon and the fraction of privacy budget already consumed, wherein the adaptive epsilon is reduced when budget consumption exceeds predefined thresholds;

(e) injecting noise drawn from a Laplace distribution with scale parameter equal to the nutrient sensitivity divided by the adaptive epsilon;

(f) tracking cumulative privacy exposure through a Privacy Exposure Index (PEI) defined as the ratio of consumed epsilon to total budget; and

(g) automatically adjusting noise intensity in response to PEI levels, wherein at least two response levels are implemented: a first level reducing epsilon allocation when PEI exceeds a first threshold, and a second level further reducing epsilon allocation when PEI exceeds a second higher threshold.

---

### Dependent Claims

**6.** The method of claim 1, wherein the genetic metabolic rate modifier γ_genetic(g) is computed using the formula:

γ_genetic = exp((1/k) × Σᵢ₌₁ᵏ ln(1/mᵢ))

where mᵢ is the metabolic modifier coefficient for the i-th Single Nucleotide Polymorphism affecting the biomarker type, and k is the total number of relevant SNPs.

**7.** The method of claim 1, wherein the circadian rhythm modifier φ_circadian(c) is determined from a lookup table of 24 hourly values comprising values for each hour from 00:00 through 23:00, ranging from approximately 0.82 at the 08:00 morning peak to approximately 1.20 at the 02:00 late-night nadir, with sub-hour linear interpolation computed as:

φ(t) = φ_current + (φ_next − φ_current) × (minute / 60)

**8.** The method of claim 1, wherein the intrinsic physiological lag Δt_base(b) comprises predetermined default values including approximately 60 minutes for glucose (reflecting digestion, absorption, and interstitial sensor diffusion delay), approximately 30 seconds for heart rate (fast autonomic neural pathway), approximately 5 minutes for heart rate variability (parasympathetic modulation time constant), approximately 20 minutes for step count (accelerometer aggregation latency), and approximately 8 hours for sleep data (full sleep cycle observation), said values being overridable per user through the adaptive self-calibration mechanism.

**9.** The method of claim 1, wherein the distance-weighted averaging for continuous signals uses Gaussian kernel weights computed as:

w_i = exp(−0.5 × (Δt_i / σ)²) × confidence_i

where Δt_i is the temporal distance from the window center and confidence_i is the measurement confidence.

**10.** The method of claim 1, further comprising computing a staleness decay for each reading as:

decay = exp(−0.693 × gap / half_life)

where gap is the time since the last reading and half_life equals the typical sampling interval for the biomarker type.

**11.** The method of claim 2, wherein the adaptive learning rate comprises initial rates of α₀ = 0.3 for the base lag channel, α₀ = 0.2 for the circadian channel, and α₀ = 0.1 for the genetic channel, each decaying with a time constant τ = 20 observations.

**12.** The method of claim 2, wherein convergence of the calibration is determined by computing a convergence score as:

convergence_score = 0.6 × improvement + 0.4 × stability

where improvement = 1 − (MAE_recent / MAE_early) and stability = 1 / (1 + std/mean), and declaring convergence when the observation count exceeds a minimum threshold and the convergence score exceeds a convergence threshold.

**13.** The method of claim 2, wherein the personal calibration profile is persisted across computing sessions, enabling continuous refinement of lag predictions over days, weeks, and months of user data.

**14.** The system of claim 3, wherein Stage 2 comprises computing genotype-adjusted reference ranges according to:

μ_genetic(b) = μ_population(b) × (1 + Σ shift_pct_i / 100)
σ_genetic(b) = σ_population(b) × (1 − 0.05 × n_variants)

with a minimum of 60% of population standard deviation, and wherein confidence in the genetic baseline is modeled as a sigmoid function: confidence = 1 / (1 + exp(−0.5 × (n − 4))).

**15.** The system of claim 3, wherein Stage 3 uses a dual-component model:

c(t) = baseline × (1 + A_c × cos(2π(h − φ_c)/24) + A_u × cos(2πh/T_u))

wherein A_c is the circadian amplitude (0.08 for glucose, 0.15 for heart rate, 0.20 for HRV), φ_c is the circadian phase with personal offset (7h for glucose, 15h for heart rate, 3h for HRV), A_u is the ultradian amplitude (0.03 for glucose, 0.02 for heart rate, 0.05 for HRV), and T_u is the ultradian period of approximately 90 minutes (1.5 hours).

**16.** The system of claim 3, wherein the blending between circadian prediction and neighbor-based estimation in Stage 3 uses a sigmoid function:

r = 1 / (1 + exp(−(gap_hours − 2.0) / 0.6))

such that short gaps weight measured neighbors and long gaps weight the circadian model.

**17.** The system of claim 3, wherein Stage 4 estimates insulin sensitivity by combining at least: a base metabolic rate, phase-specific adjustments for fasting and exercise recovery, a sleep quality penalty computed as penalty = 0.12 × (1 − sleep_quality / 0.7) when sleep quality is below 0.7, and circadian adjustments for time of day.

**18.** The system of claim 3, wherein Stage 5 comprises biomarker-reactive adjustments that reduce carbohydrate targets by up to 25% when glucose Z-score exceeds 1.5, increase carbohydrate targets by up to 20% when glucose Z-score is below −1.0, increase magnesium and vitamin B6 targets by up to 15% when HRV Z-score is below −1.0 indicating stress, and increase water targets by up to 30% when heart rate Z-score exceeds 1.0 indicating suspected dehydration.

**19.** The method of claim 4, wherein the priority hierarchy comprises six levels: Medical Critical at priority 5, Medical Warning at priority 4, Genetic Optimization at priority 3, Biomarker Reactive at priority 2, Metabolic State at priority 1, and Base RDA at priority 0, and wherein layers at priority 4 and above are never overridable.

**20.** The method of claim 5, wherein the first epsilon value for the critical tier is approximately 0.1, the second epsilon value for the high tier is approximately 0.3, the third epsilon value for the medium tier is approximately 0.5, and the fourth epsilon value for the low tier is approximately 0.8.

**21.** The method of claim 5, wherein the predefined thresholds for adaptive epsilon reduction comprise a first threshold at approximately 70% budget consumption reducing epsilon by approximately 25%, and a second threshold at approximately 90% budget consumption reducing epsilon by approximately 50%.

**22.** The method of claim 5, further comprising supporting both Laplace mechanism for pure ε-differential privacy and Gaussian mechanism for (ε,δ)-differential privacy, with σ computed as:

σ = (sensitivity × √(2 × ln(1.25/δ))) / ε

**23.** The method of claim 1, wherein:

(a) all seven processing stages (Stage 0 through Stage 6) are executed exclusively on an edge computing device physically co-located with or proximate to the user, the edge computing device comprising an ARM-based mobile system-on-chip (SoC) or equivalent processor with at least 256 MB of dedicated working memory and non-volatile persistent storage;

(b) the edge computing device is operatively coupled to at least one continuous glucose monitor (CGM) via Bluetooth Low Energy (BLE) hardware communication interface, the CGM being physically attached to the user's body via a subcutaneous electrochemical sensor filament, and to at least one wearable heart rate sensor via a second BLE hardware communication interface;

(c) the edge computing device comprises a hardware-isolated Trusted Execution Environment (TEE) or Secure Enclave in which genetic data decryption and SNP modifier coefficient computation are performed, such that raw genetic sequences are never exposed to general-purpose operating system processes;

(d) per-user calibration profiles comprising the three correction parameters (δ_base, κ_genetic, δ_circ) are persisted in the non-volatile storage across device power cycles and application sessions, enabling continuous self-calibration refinement over periods of weeks and months without data loss;

(e) the edge computing device enforces a hardware-level privacy boundary through a network interface with cryptographic schema validation, wherein outgoing network packets are validated against a whitelist schema that permits only: (i) a fixed-size 64-dimensional feature embedding vector, (ii) differential-privacy-protected aggregate statistics with noise injection as specified in Stage 6, and (iii) categorical metabolic state labels selected from a closed enumeration; and

(f) raw biomarker values, genetic data, SNP genotype sequences, individually identifiable health measurements, and per-user calibration correction parameters never leave the edge computing device under any operating condition, such that the privacy guarantee is enforced by hardware architecture rather than software policy alone.

**24.** The system of claim 3, wherein:

(a) the biomarker data is structured according to the HL7 FHIR R4 (Fast Healthcare Interoperability Resources, Release 4) international healthcare interoperability standard, wherein each BiomarkerReading comprises FHIR-compatible metadata fields including LOINC (Logical Observation Identifiers Names and Codes) observation codes for biomarker type identification, UCUM (Unified Code for Units of Measure) unit encoding, and ISO 8601 UTC timestamps;

(b) each BiomarkerReading includes a SHA-256 cryptographic integrity hash computed over the concatenation of source_id, user_id, biomarker_type, timestamp, value, and unit fields, enabling tamper detection and data provenance verification throughout the seven-stage pipeline;

(c) the privacy-protected outputs transmitted from the edge device to the server are formatted as FHIR-compliant Observation resources with appropriate coding systems, enabling direct integration with existing Electronic Health Record (EHR) systems, Health Information Exchanges (HIEs), and clinical decision support systems without format conversion;

(d) the system supports ingestion of biomarker data from FHIR-compliant data sources via standardized FHIR RESTful API endpoints (GET /Observation, POST /Observation), enabling interoperability with hospital information systems, pharmacy systems, laboratory information systems, and third-party health applications that conform to the FHIR R4 specification; and

(e) conflict resolution audit records (ConflictResolution data structures) are exportable as FHIR AuditEvent resources, providing regulatory-compliant audit trails compatible with HIPAA §164.312(b) audit control requirements and GDPR Article 30 record-keeping obligations.

**25.** The method of claim 2, wherein the peak detection algorithm comprises: (i) applying Exponential Moving Average smoothing with α = 0.3, (ii) identifying local maxima exceeding both adjacent values, (iii) computing prominence as peak value minus maximum of adjacent troughs, (iv) filtering by minimum prominence threshold of 10% of signal range, and (v) selecting the highest-prominence peak with confidence score equal to min(1.0, prominence / signal_range).

---

## ABSTRACT OF THE DISCLOSURE

A computer-implemented system and method for personalized nutrition recommendation based on dynamic physiological lag-compensated temporal synchronization of heterogeneous biomarker signals. The system computes personalized lag durations by multiplying three independent biological axes: biomarker-specific intrinsic lag (e.g., 60 minutes for glucose, 30 seconds for heart rate), genetic metabolic rate derived from SNP profiles, and circadian rhythm metabolic efficiency. An adaptive self-calibration feedback loop continuously refines lag predictions by back-propagating prediction-versus-actual peak timing errors through three independent correction channels with decaying learning rates. A seven-stage processing pipeline transforms raw biomarker readings into real-time personalized nutrient budgets through consent filtering, temporal synchronization, genotype-aware normalization, circadian-aware interpolation, composite metabolic state estimation with 14 simultaneous phases, context-aware re-normalization, nutrient demand calculation with hierarchical conflict resolution between genetic optimization and medical safety constraints, and dynamic differential privacy noise injection with four-tier sensitivity classification. The system operates on edge devices to ensure raw health data never leaves the user's device, with triple-layer privacy protection comprising edge computing, dynamic differential privacy, and granular consent management.

---

## INVENTOR(S)

**Name:** Deokhwa Jeong (정덕화)

---

## ASSIGNEE

[To be determined]

---

## FILING INFORMATION

**Application Type:** Utility Patent Application (Non-Provisional)
**Filing Date:** [To be filed]
**Technology Center:** 3600 (Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review) or 2100 (Computer Architecture, Software, and Information Security)
**Suggested CPC Classifications:**
- G16H 50/30 — ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
- G16H 20/60 — ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control
- G16H 50/20 — ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
- G06N 20/00 — Machine learning
- G06F 21/62 — Protecting access to data via a platform, e.g. using keys or access control rules

---

*© 2026 Deokhwa Jeong. All Rights Reserved.*
*This document constitutes a patent application specification. Unauthorized reproduction prohibited.*

<!-- reviewed: 2023-03-10 -->
